IP/25/PZ.4_NNP IP_NNP BULLETIN_NNP OF_IN THE_NNP PASTEUR_NNP INSTITUTE_NNP OF_NNP SOUTHERN_NNP INDIA_NNP ,_, COONOOR_NNP ._.
NO_DT ._.
3_CD ._.
1910_CD ._.
PUBLISHED_VBN UNDER_IN THE_DT AUTHORITY_NNP OF_IN THE_NNP CENTRAL_NNP COMMITTEE_NNP OF_IN THE_NNP ASSOCIATION_NNP ._.
MADRAS_NNP ._.
PRINTED_VBN BY_NNP THE_NNP SUPERINTENDENT_NNP ,_, GOVERNMENT_NNP PRESS_NNP ._.
1911_CD ._.
BULLETIN_NNP OF_IN THE_NNP PASTEUR_NNP INSTITUTE_NNP OF_NNP SOUTHERN_NNP INDIA_NNP ,_, COONOOR_NNP ._.
No_DT ._.
3_CD ._.
1910_CD ._.
PUBLISHED_VBN UNDER_IN THE_DT AUTHORITY_NNP OF_IN THE_NNP CENTRAL_NNP COMMITTEE_NNP OF_IN THE_NNP ASSOCIATION_NNP ._.
MADRAS_NN :_: PRINTED_NN BY_IN THE_NNP SUPERINTENDENT_NNP ,_, GOVERNMENT_NNP PRESS_NNP ,_, 1911_CD ._.
STAFF_NNP ._.
Director_NN :_: J._NNP W._NNP CORNWALL_NNP ,_, M.A._NNP ,_, M.D._NNP ,_, D.P.H._NNP ,_, Major_NNP ,_, I.M.S._NNP Assistant_NNP Director_NNP :_: A._NN G._NNP MCKENDRICK_NNP ,_, M.B._NNP ,_, CH.B._NNP ,_, Captain_NNP ,_, I.M.S._NNP Assistant_NNP Surgeon_NNP :_: M._NNP KESAVA_NNP PAI_NNP ,_, M.D_NNP ._.
|_JJ Sub-Assistant_JJ Surgeon_NN :_: S._NNP RAMASAMY_NNP AIYAR_NNP ._.
TABLE_NN OF_IN CONTENTS_NNP ._.
SECTION_NNP I.BULLETIN_NNP OF_IN THE_NNP PASTEUR_NNP INSTITUTE_NNP OF_NNP SOUTHERN_NNP INDIA_NNP ._.
SECTION_NN I_PRP ._.
NOTES_NNS ON_NNP RABIES_NNP ._.
I._NNP Deviation_NNP of_IN Complement_NNP by_IN Fixed_NNP Virus_NNP Brain_NNP Extract_NNP ._.
Numerous_JJ authors_NNS have_VBP recorded_VBN their_PRP$ failures_NNS to_TO obtain_VB a_DT specific_JJ deviation_NN of_IN complement_JJ reaction_NN with_IN antirabic_JJ serum_NN and_CC the_DT blood_NN ,_, brain_NN or_CC other_JJ tissue_NN of_IN an_DT animal_JJ suffering_NN from_IN rabies_NNS ,_, and_CC our_PRP$ own_JJ experiments_NNS also_RB (_( Bulletin_NNP 1_CD ,_, 1908_CD ,_, page_VB 24_CD )_) in_IN this_DT direction_NN have_VBP been_VBN ,_, until_IN recently_RB ,_, negative_JJ ._.
By_IN using_VBG extracts_NNS of_IN brains_NNS we_PRP have_VBP now_RB obtained_VBN some_DT positive_JJ results_NNS ,_, though_IN the_DT reaction_NN could_MD not_RB be_VB demonstrated_VBN at_IN will_MD ,_, even_RB when_WRB the_DT conditions_NNS which_WDT had_VBD been_VBN successful_JJ were_VBD reproduced_VBN as_RB nearly_RB as_IN possible_JJ ._.
The_DT extracts_NNS were_VBD prepared_VBN by_IN taking_VBG equal_JJ weights_NNS of_IN fixed_JJ virus_NN rabbit_NN brain_NN and_CC of_IN normal_JJ rabbit_NN brain_NN ,_, pounding_VBG them_PRP in_IN a_DT mortar_NN with_IN 0.85_CD per_IN cent_NN ._.
NaCl_NNP ,_, and_CC leaving_VBG the_DT resulting_JJ emulsions_NNS (_( 1_CD in_IN 10_CD )_) in_IN the_DT ice_NN box_NN for_IN 24_CD hours_NNS ._.
The_DT solid_JJ matter_NN was_VBD then_RB deposited_VBN by_IN centrifugation_NN and_CC the_DT faintly_RB opalescent_JJ fluids_NNS used_VBN ._.
TABLE_NN No_DT ._.
1_CD ._.
1_CD 2_CD 3_CD 4_CD 5_CD 6_CD Fresh_NNP antirabic_JJ horse_NN serum_VBD 1.0_CD 1.0_CD 1.0_CD 0.42_CD 0.42_CD 0.42_CD Extract_NNP ,_, fixed_VBD virus_NN brain_NN ._.
0.75_CD 1.2_CD Extract_NNP ,_, normal_JJ brain_NN 0.75_CD 1.2_CD Salt_NNP ,_, 0.85_CD per_IN cent_NN ._.
0.75_CD 0.13_CD 0.13_CD 1.33_CD 20_CD per_IN cent_NN ._.
sensitized_VBN sheep_JJ RBCs_NNP 0.25_CD 0.25_CD 0.25_CD 0.25_CD 0.25_CD 0.25_CD Lysis_NN ._.
Partial_NNP ._.
Complete_NNP ._.
Complete_NNP ._.
Slight_NNP ._.
Partial_NNP ._.
Nearly_RB complete_JJ ._.
The_DT extracts_NNS were_VBD incubated_VBN with_IN the_DT antirabic_JJ serum_NN for_IN 1½_CD hours_NNS before_IN the_DT sensitized_JJ RBCs_NNP were_VBD added_VBN ._.
Column_NN 1_CD shows_NNS less_JJR lysis_NN than_IN column_NN 2_CD ,_, and_CC column_NN 4_CD than_IN column_NN 5_CD ._.
The_DT amount_NN of_IN complement_NN available_JJ in_IN column_NN 2_CD was_VBD 2_CD sufficient_JJ to_TO mask_VB the_DT deviation_NN due_JJ to_TO albuminous_JJ substances_NNS in_IN the_DT extract_NN of_IN normal_JJ brain_NN which_WDT is_VBZ made_VBN evident_JJ by_IN the_DT difference_NN in_IN lysis_NN in_IN columns_NN 5_CD and.6_NN ._.
A_DT similar_JJ experiment_NN in_IN which_WDT the_DT result_NN was_VBD more_JJR marked_JJ is_VBZ shown_VBN below:3_JJ 3_CD ._.
Cutaneous_JJ Reaction_NNP in_IN Antirabic_NNP Inoculations_NNP ._.
The_DT method_NN of_IN treatment_NN in_IN this_DT Institute_NNP is_VBZ to_TO inject_VB once_RB daily_JJ 4_CD cc_NN ._.
of_IN an_DT emulsion_NN of_IN fresh_JJ fixed_VBN virus_NN for_IN a_DT period_NN of_IN 14_CD days_NNS ._.
The_DT injections_NNS are_VBP started_VBN about_IN 2_CD cm_NN ._.
below_IN the_DT umbilicus_NN and_CC 3_CD cm_NN ._.
from_IN the_DT middle_JJ line_NN ,_, and_CC 2_CD cc_NN ._.
are_VBP injected_VBN on_IN each_DT side_NN ._.
The_DT succeeding_NN injections_NNS are_VBP made_VBN in_IN straight_JJ lines_NNS directly_RB below_IN the_DT first_JJ ,_, about_RB 1.5_CD cm_NN ._.
separating_VBG each_DT puncture_NN from_IN the_DT one_CD above_IN it_PRP ._.
On_IN the_DT eighth_JJ day_NN the_DT injections_NNS are_VBP made_VBN on_IN a_DT level_NN with_IN ,_, and_CC 2.5_CD cm_NN ._.
outside_RB ,_, the_DT first_JJ ,_, on_IN the_DT ninth_JJ day_NN outside_IN the_DT second_JJ and_CC so_RB on_IN ,_, until_IN at_IN the_DT end_NN of_IN the_DT fourteenth_JJ day_NN the_DT patient_NN presents_VBZ two_CD double_JJ rows_NNS of_IN punctures_NNS ,_, fourteen_NN on_IN each_DT side_NN ._.
In_IN perhaps_RB a_DT quarter_NN of_IN the_DT total_JJ number_NN of_IN patients_NNS the_DT injections_NNS give_VBP rise_NN to_TO no_DT redness_NN or_CC swelling_VBG whatever_NN ,_, only_RB the_DT needle_JJ marks_NNS are_VBP seen_VBN during_IN and_CC at_IN the_DT end_NN of_IN the_DT treatment_NN ,_, and_CC itching_NN is_VBZ but_CC rarely_RB complained_VBD of_IN ,_, so_IN that_IN it_PRP is_VBZ only_RB in_IN persons_NNS who_WP happen_VBP to_TO have_VB a_DT short_JJ space_NN between_IN the_DT umbilicus_NN and_CC pubes_NN ,_, and_CC in_IN small_JJ children_NNS ,_, that_IN any_DT alteration_NN has_VBZ to_TO be_VB made_VBN in_IN the_DT ,_, routine_JJ lines_NNS ._.
It_PRP has_VBZ long_RB been_VBN noticed_VBN ,_, however_RB ,_, that_IN the_DT last_JJ of_IN the_DT first_JJ row_NN of_IN injections_NNS ,_, or_CC 7th_CD ,_, and_CC much_RB more_RBR frequently_RB the_DT first_JJ of_IN the_DT second_JJ row_NN ,_, or_CC the_DT 8th_CD ,_, gives_VBZ rise_NN to_TO a_DT slightly_RB elevated_VBN ,_, hyperæmic_JJ patch_NN ,_, of_IN irregular_JJ outline_NN ,_, from_IN 2.5_CD cm_NN ._.
in_IN diameter_NN ._.
The_DT 9th_CD injection_NN and_CC also_RB the_DT 10th_CD and_CC 11th_CD then_RB have_VB to_TO be_VB more_RBR spaced_JJ out_IN ,_, for_IN a_DT puncture_NN into_IN one_CD of_IN these_DT hyperæmic_JJ areas_NNS leads_VBZ to_TO a_DT little_JJ bleeding_NN which_WDT it_PRP is_VBZ as_RB well_RB to_TO avoid_VB ._.
In_IN such_JJ persons_NNS the_DT 12th_CD ,_, 13th_CD and_CC 14th_CD injections_NNS can_MD not_RB be_VB fitted_VBN into_IN the_DT space_NN available_JJ ,_, and_CC a_DT third_JJ row_NN has_VBZ to_TO be_VB formed_VBN ,_, or_CC one_CD or_CC two_CD put_NN in_IN above_IN the_DT umbilicus_NN ._.
The_DT 8th_CD ,_, 9th_CD and_CC 10th_CD injections_NNS are_VBP the_DT ones_NNS which_WDT cause_VBP the_DT most_RBS noticeable_JJ reaction_NN ;_: and_CC the_DT patients_NNS who_WP are_VBP affected_VBN complain_NN a_DT good_JJ deal_NN of_IN the_DT itching_NN ._.
The_DT 11th-14th_JJ injections_NNS give_VBP less_JJR reaction_NN and_CC the_DT itching_VBG becomes_RB less_RBR ._.
When_WRB a_DT reaction_NN appears_VBZ after_IN the_DT first_JJ or_CC second_JJ injections_NNS it_PRP is_VBZ generally_RB a_DT sign_NN that_IN the_DT health_NN of_IN the_DT patient_NN is_VBZ not_RB perfect_JJ ,_, he_PRP is_VBZ alcoholic_JJ ,_, dyspeptic_JJ ,_, or_CC obese_JJ ;_: and_CC the_DT reaction_NN is_VBZ probably_RB an_DT indication_NN that_IN the_DT absorptive_JJ power_NN of_IN his_PRP$ sub-_JJ cutaneous_JJ tissue_NN is_VBZ not_RB good_JJ ._.
It_PRP has_VBZ not_RB been_VBN noticed_VBN that_IN such_JJ persons_NNS exhibit_VBP more_JJR severe_JJ reactions_NNS about_IN the_DT seventh_JJ day_NN than_IN healthy_JJ subjects_NNS ._.
Reactions_NNS on_IN the_DT eighth_JJ day_NN have_VBP seldom_VBN been_VBN observed_VBN in_IN persons_NNS with_IN no_DT subcutaneous_JJ fatty_NNS layer_NN and_CC a_DT skin_NN so_RB loose_JJ that_IN a_DT prominent_JJ moveable_JJ ball_NN is_VBZ the_DT immediate_JJ result_NN of_IN an_DT injection_NN ._.
On_IN the_DT other_JJ hand_NN ,_, women_NNS ,_, who_WP have_VBP a_DT thick_JJ layer_NN of_IN sub-cutaneous_JJ fat_NN ,_, seem_VBP to_TO react_VB but_CC rarely_RB ._.
An_DT eighth_JJ day_NN reaction_NN consisting_VBG merely_RB of_IN a_DT pink_JJ area_NN ,_, say_VBP 3_CD cm_NN ._.
in_IN diameter_NN ,_, without_IN swelling_VBG or_CC itching_NN ,_, which_WDT would_MD pass_VB unnoticed_JJ in_IN a_DT dark_NN skinned_JJ Indian_JJ ,_, is_VBZ obvious_JJ in_IN unpigmented_JJ skins_NNS ._.
The_DT reaction_NN has_VBZ never_RB been_VBN regarded_VBN in_IN this_DT Institute_NNP as_IN indicative_NN of_IN a_DT specific_JJ susceptibility_NN to_TO rabies_NNS ,_, nor_CC can_MD it_PRP be_VB supposed_VBN to_TO afford_VB any_DT information_NN as_IN to_TO the_DT progress_NN of_IN immunity_NN as_IN a_DT result_NN of_IN the_DT inoculations_NNS ._.
Stimson_NNP ,_, who_WP has_VBZ lately_RB called_VBN attention_NN to_TO this_DT reaction_NN for_IN the_DT first_JJ time_NN in_IN print_NN (_( Journal_NNP of_IN Medical_NNP Research_NNP ,_, November_NNP 1910_CD )_) has_VBZ been_VBN more_RBR precise_JJ in_IN his_PRP$ observations_NNS than_IN we_PRP have_VBP ,_, and_CC gives_VBZ a_DT graphic_JJ representation_NN of_IN the_DT intensity_NN of_IN the_DT reaction_NN which_WDT culminates_VBZ on_IN the_DT eighth_JJ and_CC ninth_JJ days_NNS ;_: but_CC he_PRP does_VBZ not_RB seem_VB to_TO draw_VB a_DT sharp_JJ enough_JJ distinction_NN between_IN the_DT really_RB specific_JJ reaction_NN ,_, which_WDT ,_, as_IN our_PRP$ observations_NNS go_VBP ,_, does_VBZ not_RB manifest_VB itself_PRP earlier_JJR than_IN the_DT sixth_JJ day_NN and_CC most_RBS frequently_RB the_DT eighth_NN ,_, and_CC the_DT swelling_VBG due_JJ to_TO local_JJ irritation_NN and_CC faulty_NN absorptive_JJ power_NN in_IN persons_NNS who_WP are_VBP below_IN par_NN in_IN health_NN ._.
The_DT reaction_NN is_VBZ evanescent_JJ in_IN a_DT certain_JJ number_NN of_IN people_NNS and_CC nearly_RB all_DT trace_NN of_IN it_PRP may_MD have_VB disappeared_VBN within_IN 24_CD hours_NNS ._.
Stimson_NNP has_VBZ observed_VBN also_RB that_RB ,_, when_WRB a_DT reaction_NN occurs_VBZ suddenly_RB after_IN any_DT one_CD puncture_NN ,_, it_PRP may_MD be_VB evident_JJ ,_, not_RB at_IN that_DT site_NN only_RB ,_, but_CC at_IN the_DT site_NN of_IN several_JJ previous_JJ punctures_NNS ._.
This_DT is_VBZ beyond_IN our_PRP$ experience_NN ,_, which_WDT is_VBZ that_IN it_PRP is_VBZ not_RB uncommon_JJ for_IN several_JJ punctures_NNS to_TO be_VB in_IN reaction_NN at_IN the_DT same_JJ time_NN ,_, i.e._FW ,_, the_DT reaction_NN at_IN any_DT one_CD spot_NN may_MD last_JJ several_JJ days_NNS ._.
We_PRP have_VBP never_RB noticed_VBN for_IN example_NN the_DT 8th_CD puncture_NN to_TO show_VB a_DT reaction_NN after_IN the_DT 10th_JJ injection_NN :_: if_IN the_DT 8th_CD puncture_NN intends_VBZ to_TO react_VB it_PRP will_MD A-I_VB 4_CD show_NN unmistakeable_JJ signs_NNS on_IN the_DT 9th_CD morning_NN ._.
Stimson_NNP ,_, however_RB ,_, was_VBD probably-_JJ working_VBG with_IN dried_JJ cord_NN emulsions_NNS which_WDT may_MD have_VB introduced_VBN other_JJ factors_NNS ._.
His_PRP$ conclusion_NN we_PRP accept_VBP in_IN default_NN of_IN a_DT better_JJR :_: ``_`` the_DT reaction_NN would_MD therefore_VB seem_VB to_TO be_VB caused_VBN by_IN the_DT foreign_JJ proteid_NN of_IN the_DT rabbit_NN nervous_JJ tissue_NN itself_PRP and_CC (_( is_VBZ )_) an_DT expression_NN of_IN hypersensibility_NN established_VBN by_IN the_DT early_JJ injections_NNS ._. ''_''
SECTION_NNP II_NNP ._.
HÆMOLYTIC_NNP DATA_NNP ._.
I_PRP ._.
Some_DT Factors_NNS which_WDT influence_VBP the_DT Lysis_NN of_IN Erythrocytes_NNS by_IN Hypotonicity_NNP ._.
(_( I_PRP )_) ._.
During_IN the_DT course_NN of_IN endeavours_NNS to_TO define_VB the_DT physical_JJ conditions_NNS which_WDT tend_VBP to_TO promote_VB and_CC to_TO inhibit_VB hæmolysis_NN by_IN a_DT specific_JJ serum_NN it_PRP was_VBD noticed_VBN that_IN the_DT range_NN of_IN lysis_NN of_IN RBCs_NNP of_IN different_JJ species_NNS of_IN animals_NNS seemed_VBD to_TO occupy_VB distinct_JJ spaces_NNS on_IN the_DT scale_NN of_IN NaCl_NNP solutions_NNS of_IN varying_VBG degrees_NNS of_IN concentration_NN ._.
To_TO ascertain_VB whether_IN any_DT relation_NN exists_VBZ between_IN the_DT resistance_NN of_IN RBCs_NNP to_TO hypotonic_VB lysis_NN and_CC their_PRP$ resistance_NN to_TO lysis_VB by_IN serums_NNS a_DT number_NN of_IN observations_NNS was_VBD made_VBN on_IN the_DT RBCs_NNP of_IN eight_CD species_NNS with_IN the_DT view_NN of_IN arranging_VBG them_PRP in_IN order_NN of_IN resistances_NNS ._.
Method.To_NNP face_NN page_NN 4_CD CHART_NNP No_NNP ._.
1_CD Position_NN on_IN the_DT salt_NN percentage_NN scale_NN of_IN the_DT mean_JJ range_NN of_IN lysis_NN of_IN the_DT R_NNP B_NNP Cs_NNP ._.
of_IN eight_CD species_NNS ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 74918115.tif_CD ]_JJ Position_NN on_IN the_DT salt_NN percentage_NN scale_NN of_IN the_DT mean_JJ range_NN of_IN lysis_NN of_IN erythrocytes_NNS from_IN eight_CD different_JJ species_NNS ._.
Percentage_NN NaCl_NNP S.O./1911_NNP Reg_NNP :_: No_DT ._.
1268_CD Copies_VBZ 5_CD This_DT point_NN ,_, approximately_RB ,_, may_MD be_VB considered_VBN to_TO be_VB as_IN follows:6_JJ The_DT removal_NN of_IN the_DT NaCl_NNP renders_VBZ the_DT cell_NN more_RBR resistant_JJ to_TO lysis_NN :_: one_CD concludes_VBZ ,_, therefore_RB ,_, that_IN the_DT negative_JJ ion_NN is_VBZ the_DT dominant_JJ one_CD ,_, for_IN when_WRB NaCl_NNP is_VBZ re-supplied_JJ the_DT cell_NN resistance_NN again_RB falls_VBZ ._.
The_DT fact_NN of_IN the_DT increase_NN of_IN resistance_NN of_IN RBCs_NNP following_VBG removal_NN of_IN ._.
NaCl_NNP has_VBZ been_VBN noticed_VBN previously_RB by_IN Bang_NNP (_( Biochem_NNP ._.
Zeit_NNP ._.
XVI_NN ,_, p._RB 225_CD )_) ._.
*_JJ *_NNP *_NNP *_NNP *_NNP (_( 4_CD )_) Augmentation_NN of_IN the_DT acidity_NN of_IN a_DT suspension_NN of_IN RBCs_NNP by_IN the_DT passage_NN of_IN CO2_NNP causes_VBZ lysis_NN ._.
RBCs_NNP suspended_VBD in_IN 0.85_CD per_IN cent_NN ._.
NaCl_NNP are_VBP rapidly_RB lysed_VBN by_IN the_DT passage_NN of_IN CO2_NNP ;_: suspended_VBN in_IN 8_CD per_IN cent_NN ._.
sugar_NN they_PRP are_VBP not_RB lysed_VBN ;_: in_IN 2_CD per_IN cent_NN ._.
NaCl_NNP lysis_NN is_VBZ hindered_VBN until_IN Hb_NNP is_VBZ reduced_VBN ;_: in_IN sodium_NN citrate_NN 2.55_CD per_IN cent_NN ._.
Hb_NNP is_VBZ reduced_VBN ,_, no_DT lysis_NN ;_: in_IN Na2CO3_NNP ,_, 1_CD in_IN 3300_CD in_IN 0.85_CD per_IN cent_NN ._.
NaCl_NNP ,_, lysis_NN ;_: in_IN NaH_NNP CO3_NNP 1_CD in_IN 2000_CD in_IN 0.85_CD per_IN cent_NN ._.
NaCl_NNP ,_, reduction_NN of_IN Hb_NNP ,_, slight_VBD lysis_NN after_IN a_DT long_JJ time_NN ;_: defibrinated_VBN goat_NN blood_NN was_VBD not_RB lysed_VBN ,_, but_CC ,_, when_WRB diluted_VBN with_IN 1_CD per_IN cent_NN ._.
NaCl_NNP lysis_NN quickly_RB followed_VBD ._.
Lysis_NN by_IN CO2_NNP seems_VBZ to_TO depend_VB on_IN the_DT chemical_JJ composition_NN of_IN the_DT medium_NN of_IN suspension_NN :_: when_WRB it_PRP can_MD act_VB directly_RB on_IN the_DT RBCs_NNP lysis_NN is_VBZ rapid_JJ ,_, if_IN ,_, however_RB ,_, there_EX is_VBZ an_DT unsaturated_JJ substance_NN such_JJ as_IN NaHCO3_NNP present_NN ,_, lysis_NN is_VBZ delayed_VBN until_IN the_DT affinities_NNS of_IN that_DT substance_NN have_VBP been_VBN satisfied_VBN ._.
Serum_NNP appears_VBZ to_TO absorb_VB a_DT large_JJ volume_NN of_IN CO2_NNP ._.
Experiments_NNS by_IN Hamburger_NNP and_CC Van_NNP Lier_NNP (_( related_VBN in_IN Engelmann_NNP 's_POS Arch_NNP ._.
Physiol_NNP ._.
page_NN 492_CD ,_, 1902_CD )_) show_NN that_IN by_IN the_DT passage_NN of_IN CO2_NNP through_IN blood_NN or_CC through_IN a_DT suspension_NN of_IN RBCs_NNP in_IN salt_NN solution_NN the_DT alkalinity_NN of_IN the_DT fluid_NN is_VBZ increased_VBN ._.
To_TO what_WP extent_NN this_DT occurs_VBZ in_IN the_DT circulating_NN blood_NN when_WRB there_EX is_VBZ an_DT excess_NN of_IN CO2_NNP in_IN the_DT air_NN breathed_VBD does_VBZ not_RB seem_VB to_TO have_VB been_VBN ascertained_VBN ._.
No_DT such_JJ formation_NN of_IN alkalinity_NN is_VBZ observed_VBN after_IN the_DT passage_NN of_IN CO2_NNP through_IN RBCs_NNP freed_VBP from_IN NaCl_NNP and_CC suspended_VBN in_IN isotonic_JJ sugar_NN or_CC Na2SO4_NNP solutions_NNS ._.
The_DT explanation_NN offered_VBN by_IN the_DT above-named_JJ authors_NNS is_VBZ that_IN CO2_NNP penetrates_VBZ the_DT RBCs_NNP and_CC reacts_NNS with_IN their_PRP$ protein_NN contents_NNS forming_VBG carbonates_NNS ._.
The_DT envelope_NN is_VBZ permeable_JJ to_TO kations_NNS so_RB Cl_NNP '_POS passes_NNS in_IN and_CC CO3_NNP ''_'' and_CC HCO3_NNP '_POS pass_NN out_IN ,_, rendering_VBG the_DT suspending_VBG fluid_JJ alkaline_NN ._.
For_IN every_DT CO3_NNP ''_'' molecule_NN passing_VBG out_RP two_CD Cl_NNP '_POS molecules_NNS must_MD pass_VB in_IN and_CC likewise_VB sufficient_JJ water_NN to_TO equalise_VB the_DT osmotic_JJ pressure_NN ._.
Hence_RB the_DT lysis_NN of_IN the_DT RBCs_NNP ._.
When_WRB RBCs_NNP are_VBP suspended_VBN in_IN sucrose_NN there_EX is_VBZ no_DT interchange_NN of_IN kations_NNS and_CC no_DT lysis_NN ;_: when_WRB suspended_VBN in_IN Na2SO4_NNP the_DT SO4_NNP ''_'' balances_VBZ the_DT CO3_NNP ''_'' and_CC there_EX is_VBZ no_DT entrance_NN of_IN water_NN and_CC so_RB no_DT lysis_NN ._.
If_IN a_DT neutral_JJ salt_NN of_IN a_DT tribasic_JJ acid_NN could_MD be_VB found_VBN for_IN a_DT suspending_NN fluid_NN which_WDT had_VBD no_DT specific_NN ._.
action_NN on_IN RBCs_NNP and_CC did_VBD not_RB react_VB with_IN CO2_NNP ,_, lysis_NN on_IN the_DT passage_NN of_IN CO2_NNP would_MD probably_RB not_RB occur_VB ,_, for_IN the_DT RBCs_NNP would_MD lose_VB water_NN ._.
*_JJ *_NNP *_NNP *_NNP *_NNP (_( 5_CD )_) To_TO find_VB if_IN treatment_NN with_IN a_DT foreign_JJ serum_NN has_VBZ any_DT effect_NN on_IN the_DT resistance_NN of_IN RBCs_NNP to_TO lysis_VB by_IN hypotonicity_NN ,_, guinea-pig_JJ RBCs_NNP were_VBD subjected_VBN to_TO the_DT action_NN of_IN horse_NN serum_NN which_WDT normally_RB has_VBZ scarcely_RB any_DT lytic_JJ action_NN on_IN them_PRP ,_, though_IN it_PRP agglutinates_VBZ them_PRP ._.
Washed_VBN guinea-pig_JJ RBCs_NNP were_VBD divided_VBN into_IN three_CD portions_NNS of_IN 1.5_CD cc_NNS each_DT ,_, ._.
A_DT was_VBD suspended_VBN in_IN 10_CD cc_NN of_IN 0.85_CD per_IN cent_NN ._.
NaCl_NNP ,_, B_NNP in_IN 10_CD cc_NN of_IN fresh_JJ horse_NN serum_NN ,_, C_NNP in_IN 10_CD cc_NN of_IN heated_JJ horse_NN serum_NN 55°C_CD ,_, and_CC the_DT three_CD tubes_NNS were_VBD kept_VBN at_IN 37°C_CD for_IN 2_CD hours_NNS ,_, then_RB centrifugated_VBD ,_, washed_VBD twice_RB in_IN salt_JJ solution_NN and_CC put_VBD up_RP with_IN hypotonic_JJ NaCl_NNP solutions_NNS with_IN the_DT result_NN shown_VBN below_IN ,_, expressed_VBN in_IN percentages_NNS of_IN NaCl_NNP :_: To_TO face_VB page_NN 7_CD CHART_NNP No_NNP ._.
2_CD Chart_NNP showing_VBG the_DT effect_NN of_IN equi-_JJ molecular_JJ solutions_NNS of_IN different_JJ salts_NNS on_IN lysis_NN by_IN a_DT specific_JJ serum_NN ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 74918130.tif_CD ]_JJ T_NNP =_NNP Trace_NNP lysis_NN S_NNP =_NNP Slight_NNP 7_CD (_( 6_CD )_) Experiments_NNS were_VBD made_VBN to_TO determine_VB whether_IN the_DT inhibition_NN of_IN specific_JJ lysis_NN by_IN different_JJ metallic_JJ salts_NNS is_VBZ related_VBN to_TO their_PRP$ respective_JJ molecular_JJ weights_NNS ._.
Calcium_NNP chloride_NN and_CC magnesium_NN sulphate_NN were_VBD heated_VBN to_TO 200°C_CD to_TO render_VB them_PRP anhydrous_JJ ,_, and_CC equimolecular_JJ solutions_NNS of_IN these_DT and_CC of_IN dried_JJ sodium_NN chloride_NN were_VBD prepared_VBN ._.
1_CD per_IN cent_NN ._.
NaCl_NNP =_VBD 1.89_CD per_IN cent_NN ._.
CaCl2_NNP =_VBD 2.06_CD per_IN cent_NN ._.
MgSO4_NNP ._.
Proportionally_RB increasing_VBG strengths_NNS of_IN these_DT solutions_NNS were_VBD used_VBN as_IN the_DT diluting_VBG agents_NNS in_IN a_DT hæmolytic_JJ system_NN consisting_VBG of_IN sheep_JJ RBCs_NNP sensitized_VBN in_IN goat-_JJ antisheep-serum_JJ with_IN fresh_JJ sheep_NN serum_NN complement_NN ._.
The_DT inhibitory_JJ action_NN as_IN shown_VBN by_IN the_DT diagrams_NNS (_( chart_JJ No_NNP ._.
2_CD )_) was_VBD greatest_JJS in_IN the_DT case_NN of_IN CaCl2_NNP ,_, next_IN of_IN MgSO4_NNP and_CC least_JJS of_IN NaCl_NNP ._.
It_PRP is_VBZ evident_JJ that_IN the_DT prevention_NN of_IN lysis_NN is_VBZ not_RB a_DT function_NN of_IN the_DT molecular_JJ weight_NN of_IN a_DT salt_NN ,_, but_CC depends_VBZ on_IN some_DT other_JJ property_NN such_JJ as_IN the_DT degree_NN of_IN ionisation_NN ._.
As_IN regards_NNS lysis_NN by_IN hypotonicity_NN the_DT following_JJ strengths_NNS of_IN the_DT above_NN salts_NNS are_VBP approximately_RB equivalent:8_JJ method_NN of_IN decomplementing_VBG a_DT serum_NN ._.
We_PRP have_VBP found_VBN that_IN equally_RB good_JJ results_NNS can_MD be_VB obtained_VBN by_IN using_VBG RBCs_NNP heated_VBD for_IN a_DT shorter_JJR time_NN to_TO a_DT higher_JJR temperature_NN ._.
All_DT that_DT is_VBZ necessary_JJ is_VBZ to_TO heat_VB the_DT RBCs_NNP in_IN a_DT tube_NN in_IN a_DT waterbath_NN until_IN they_PRP are_VBP thoroughly_RB browned_VBN and_CC aggregate_VB in_IN clumps_NNS ,_, leaving_VBG the_DT fluid_NN clear_JJ or_CC slightly_RB brownish_JJ ._.
Provided_VBN with_IN such_JJ heated_VBN RBCs_IN it_PRP can_MD easily_RB be_VB shown_VBN that_IN ,_, unless_IN they_PRP have_VBP absorbed_VBN amboceptor_NN ,_, they_PRP will_MD not_RB absorb_VB complement_NN ;_: e.g._CC ,_, horse_NN serum_NN ,_, which_WDT contains_VBZ little_JJ or_CC no_DT amboceptor_NN for_IN rabbit_NN RBCs_NNP ,_, can_MD not_RB be_VB decomple-_JJ mented_VBN by_IN rabbit_NN RBCs_NNP ,_, whereas_JJ sheep_NN serum_NN which_WDT normally_RB lyses_VBZ rabbit_NN RBCs_NNP strongly_RB can_MD be_VB completely_RB decomplemented_VBN by_IN treatment_NN with_IN heated_JJ rabbit_NN RBCs_NNP ._.
In_IN heating_VBG various_JJ kinds_NNS of_IN RBCs_NNP for_IN these_DT experiments_NNS we_PRP noticed_VBD that_IN there_EX were_VBD considerable_JJ differences_NNS in_IN the_DT temperatures_NNS required_VBN for_IN the_DT browning_NN and_CC in_IN the_DT time_NN the_DT heat_NN had_VBD to_TO be_VB maintained_VBN ._.
Slight_JJ lysis_NN is_VBZ the_DT first_JJ effect_NN of_IN the_DT heat_NN on_IN all_DT RBCs_NNP ,_, but_CC it_PRP is_VBZ more_RBR marked_VBN in_IN some_DT species_NNS than_IN in_IN others_NNS ._.
We_PRP thought_VBD it_PRP might_MD be_VB possible_JJ to_TO arrange_VB the_DT RBCs_NNP of_IN different_JJ species_NNS in_IN order_NN ,_, with_IN regard_NN to_TO the_DT degree_NN of_IN temperature_NN required_VBN to_TO brown_VB and_CC clump_VB them_PRP and_CC the_DT duration_NN of_IN its_PRP$ application_NN ,_, but_CC after_IN some_DT trials_NNS it_PRP appeared_VBD that_IN the_DT experi-_JJ ments_NNS would_MD require_VB more_JJR time_NN than_IN could_MD be_VB spared_VBN for_IN them_PRP ._.
The_DT variations_NNS are_VBP ,_, however_RB ,_, so_RB well_RB marked_VBN that_IN such_JJ an_DT arrangement_NN would_MD probably_RB be_VB quite_RB feasible_JJ ,_, in_IN spite_NN of_IN the_DT non-existence_NN of_IN a_DT definite_JJ coagulation_NN temperature_NN ._.
The_DT coagulation_NN of_IN hæmoglobin_NN is_VBZ said_VBD to_TO take_VB place_NN logarithmically_RB ,_, the_DT coagula-_JJ tion_NN rate_NN at_IN any_DT moment_NN being_VBG proportional_JJ to_TO the_DT concentration_NN of_IN uncoagulated_JJ protein_NN ._.
The_DT temperature_NN coefficient_NN for_IN Hb_NNP =_NNP 1.3_CD per_IN degree_NN C._NNP ,_, i.e._NN ,_, increase_NN in_IN amount_NN coagulated_VBN ._.
There_EX is_VBZ therefore_RB no_DT definite_JJ coagulation_NN temperature_NN ,_, as_IN coagulation_NN proceeds_NNS at_IN different_JJ rates_NNS at_IN different_JJ temperatures_NNS ._.
*_JJ *_NNP *_NNP *_NNP *_NNP (_( 3_CD )_) The_DT union_NN of_IN RBC_NNP receptor_NN and_CC specific_JJ amboceptor_NN is_VBZ generally_RB held_VBN to_TO be_VB a_DT chemical_NN one_CD ,_, and_CC the_DT only_JJ method_NN of_IN dissociation_NN hitherto_NN published_VBN is_VBZ to_TO place_VB unsensitized_JJ RBCs_NNP in_IN contact_NN with_IN fully_RB sensitized_VBN ones_NNS ,_, which_WDT results_NNS in_IN the_DT transference_NN of_IN a_DT portion_NN of_IN the_DT sensitizer_NN from_IN the_DT latter_NN to_TO the_DT former_JJ ._.
It_PRP seemed_VBD of_IN interest_NN to_TO determine_VB whether_IN the_DT destruction_NN of_IN sensitized_VBN RBCs_NNP by_IN hypotonicity_NN leads_NNS to_TO a_DT disruption_NN of_IN this_DT union_NN ,_, or_CC whether_IN the_DT resulting_VBG fluid_NN still_RB ._.
retains_VBZ the_DT power_NN of_IN absorbing_VBG complement_NN ._.
Muir_NNP (_( Studies_NNPS on_IN Immunity_NNP )_) has_VBZ shown_VBN that_IN the_DT stromata_NN of_IN lysed_JJ RBCs_NNP retain_VBP the_DT power_NN of_IN absorbing_VBG both_DT amboceptor_NN and_CC complement_NN when_WRB separated_VBN by_IN centrifugation_NN from_IN a_DT lysed_JJ suspension_NN ,_, but_CC his_PRP$ experiment_NN does_VBZ not_RB cover_VB the_DT possible_JJ dissociation_NN of_IN the_DT amboceptor_NN molecule_NN by_IN distilled_JJ water_NN from_IN its_PRP$ attach-_JJ ment_NN to_TO a_DT RBC_NNP ._.
We_PRP took_VBD 10_CD cc_NN washed_VBD sheep_JJ RBCs_NNP ,_, sensitized_VBN in_IN goat_NN antisheep_NN serum_NN ,_, and_CC lysed_VBD them_PRP in_IN 48_CD cc_NN distilled_VBN water_NN (_( Fluid_NNP A_NNP )_) ._.
10_CD cc_NN of_IN unsensitized_JJ sheep_JJ RBCs_NNP were_VBD similarly_RB lysed_VBN (_( Fluid_NNP B_NNP )_) ._.
NaCl_NNP was_VBD added_VBN to_TO both_DT fluids_NNS to_TO 0.85_CD per_IN cent_NN ._.
Series_NNS were_VBD put_VBN up_IN of_IN the_DT two_CD fluids_NNS ,_, with_IN varying_VBG quantities_NNS of_IN fresh_JJ sheep_JJ serum_NN as_IN complement_NN ,_, and_CC were_VBD incubated_VBN for_IN half_PDT an_DT hour_NN at_IN 37°C_CD ._.
A_DT sus-_JJ pension_NN of_IN sensitized_JJ sheep_JJ RBCs_NNP was_VBD then_RB added_VBN and_CC the_DT series_NN again_RB incubated_JJ ._.
No_DT complement_NN was_VBD abstracted_VBN from_IN the_DT series_NN containing_VBG fluid_NN B_NNP ,_, and_CC the_DT several_JJ tubes_NNS showed_VBD precisely_RB the_DT same_JJ degree_NN of_IN lysis_NN as_IN did_VBD the_DT control_NN series_NN (_( 0.1_CD cc_NN complement_NN =_NNP C_NNP lysis_NN )_) ,_, whereas_UH ,_, in_IN the_DT series_NN containing_VBG fluid_NN A_NNP ,_, so_RB much_JJ complement_NN had_VBD been_VBN fixed_VBN by_IN the_DT fluid_NN that_IN 1.0_CD cc_NNS did_VBD not_RB give_VB complete_JJ lysis_NN of_IN the_DT added_JJ RBCs_NNP ._.
It_PRP is_VBZ evident_JJ that_IN hypotonic_JJ lysis_NN of_IN sensitized_JJ RBCs_NNP neither_CC dissolves_VBZ the_DT union_NN between_IN sensitizer_NN and_CC RBC_NNP receptor_NN ,_, nor_CC does_VBZ it_PRP prevent_VB the_DT subsequent_JJ absorption_NN of_IN complement_NN ._.
The_DT converse_NN of_IN this_DT experiment_NN ,_, as_IN was_VBD to_TO be_VB expected_VBN ,_, led_VBN to_TO the_DT conclu-_JJ sion_NN that_IN lysed_VBD RBCs_NNP unite_JJ with_IN amboceptor_NN and_CC complement_NN just_RB as_RB well_RB as_IN un-_JJ injured_JJ RBCs_NNP and_CC that_IN their_PRP$ disruption_NN is_VBZ a_DT purely_RB mechanical_JJ phenomenon_NN which_WDT does_VBZ not_RB alter_VB their_PRP$ combining_NN affinities_NNS in_IN the_DT least_JJS ._.
9_CD This_DT experiment_NN was_VBD performed_VBN by_IN lysing_VBG 17_CD cc_NN washed_VBD sheep_JJ RBCs_NNP in_IN 85_CD cc_NN distilled_JJ water_NN and_CC adding_VBG NaCl_NNP to_TO 0.85_CD per_IN cent_NN ._.
Series_NNS were_VBD then_RB put_VBN up_RP ,_, (_( A_DT )_) containing_VBG specific_JJ sensitizing_VBG serum_NN and_CC complement_NN ,_, and_CC (_( B_NNP )_) containing_VBG an_DT equal_JJ quantity_NN of_IN a_DT non-specific_JJ serum_NN with_IN complement_NN ._.
Both_DT were_VBD then_RB incu-_JJ bated_VBN ._.
Sensitized_VBN sheep_JJ RBCs_NNP were_VBD subsequently_RB added_VBN and_CC the_DT tubes_NNS again_RB incubated_VBN ._.
It_PRP was_VBD then_RB found_VBN that_IN the_DT disrupted_VBN RBCs_NNP (_( A_NNP )_) had_VBD combined_VBN with_IN ._.
the_DT sensitizer_NN and_CC removed_VBD complement_NN ,_, so_IN that_DT in_IN series_NN (_( A_NNP )_) complete_JJ lysis_NN was_VBD shown_VBN by_IN a_DT tube_NN containing_VBG 0.25_CD cc_JJ complement_NN ,_, whereas_NNS in_IN series_NN (_( B_NNP )_) 0.06_CD cc_JJ complement_NN produced_VBD complete_JJ lysis_NN ._.
The_DT occurrence_NN of_IN lysis_NN is_VBZ ,_, therefore_RB ,_, a_DT purely_RB accidental_JJ phenomenon_NN ,_, and_CC the_DT liberation_NN of_IN hæmoglobin_NN is_VBZ simply_RB an_DT indication_NN that_IN amboceptor_NN and_CC complement_NN have_VBP united_VBN with_IN some_DT part_NN of_IN the_DT substance_NN of_IN the_DT RBC_NNP and_CC is_VBZ not_RB an_DT integral_JJ part_NN of_IN the_DT reaction_NN ._.
*_JJ *_NNP *_NNP *_NNP *_NNP (_( 4_CD )_) The_DT effect_NN of_IN inspissation_NN and_CC desiccation_NN on_IN a_DT specific_JJ amboceptor_NN appears_VBZ to_TO be_VB small_JJ ._.
Goat_NNP antisheep_NN serum_NN was_VBD inspissated_VBN at_IN 70°C_CD ._.
On_IN breaking_VBG up_RP the_DT jelly_RB next_JJ day_NN and_CC extracting_VBG it_PRP with_IN distilled_JJ water_NN equal_JJ in_IN quantity_NN to_TO the_DT original_JJ bulk_NN of_IN serum_NN ,_, the_DT extract_NN was_VBD found_VBN to_TO contain_VB the_DT sensitizer_NN unimpaired_VBN in_IN quality_NN as_RB far_RB as_IN could_MD be_VB judged_VBN by_IN comparing_VBG its_PRP$ action_NN with_IN that_DT of_IN the_DT original_JJ serum_NN ._.
Extract_NN prepared_VBN from_IN another_DT portion_NN of_IN the_DT inspissated_JJ serum_NN which_WDT had_VBD been_VBN kept_VBN in_IN the_DT ice_NN box_NN showed_VBD considerable_JJ deterioration_NN after_IN 20_CD days_NNS ._.
Serum_NNP desiccated_VBD rapidly_RB in_IN vacuo_NN over_IN H2SO4_NNP retains_VBZ its_PRP$ sensitizing_VBG power_NN nearly_RB unimpaired_VBD for_IN at_IN least_JJS six_CD months_NNS ,_, when_WRB kept_NN at_IN room_NN temperature_NN (_( 15°-20°_JJ C_NNP )_) ._.
Even_RB after_IN 20_CD days_NNS such_JJ a_DT desiccated_JJ serum_NN had_VBD not_RB entirely_RB lost_VBN its_PRP$ complement_NN ._.
*_JJ *_NNP *_NNP *_NNP *_NNP (_( 5_CD )_) The_DT sensitizing_NN molecule_NN is_VBZ attached_VBN to_TO the_DT globulin_JJ fraction_NN of_IN the_DT serum_NN and_CC is_VBZ easily_RB precipitable_JJ with_IN the_DT globulin_NN by_IN the_DT saturation_NN of_IN an_DT immune_JJ serum_NN with_IN MgSO4_NNP ,_, or_CC semisaturation_NN with_IN (_( NH4_NNP )_) 2SO4_CD ._.
For_IN example_NN ,_, the_DT serum_NN of_IN a_DT pony_NN ,_, which_WDT had_VBD been_VBN immunised_VBN with_IN sheep_JJ RBCs_NNP was_VBD semisaturated_VBN with_IN (_( NH4_NNP )_) 2SO4_CD by_IN adding_VBG slowly_RB an_DT equal_JJ bulk_NN of_IN saturated_JJ solution_NN of_IN (_( NH4_NNP )_) 2SO4_CD ._.
The_DT precipitate_NN was_VBD collected_VBN on_IN a_DT filter_NN and_CC redissolved_VBN in_IN another_DT portion_NN of_IN saturated_VBN (_( NH4_NNP )_) 2SO4_CD and_CC a_DT third_JJ time_NN precipitated_VBN ._.
Finally_RB the_DT precipitate_NN was_VBD dissolved_VBN in_IN a_DT quantity_NN of_IN distilled_JJ water_NN equal_JJ to_TO the_DT original_JJ serum_NN and_CC dialysed_VBN in_IN running_VBG water_NN for_IN 72_CD hours_NNS to_TO get_VB rid_JJ of_IN the_DT (_( NH4_NNP )_) 2SO4_CD ._.
A_DT few_JJ drops_NNS of_IN chloroform_NN were_VBD added_VBN to_TO prevent_VB decomposition_NN during_IN dialysis_NN ._.
The_DT tonicity_NN of_IN the_DT solution_NN was_VBD then_RB ascertained_VBN by_IN means_NNS of_IN RBCs_NNP ,_, and_CC sufficient_JJ NaCl_NNP was_VBD added_VBN to_TO bring_VB it_PRP up_IN to_TO 0.85_CD per_IN cent_NN ._.
A_DT series_NN of_IN tubes_NNS ,_, put_VBD up_RP with_IN fresh_JJ sheep_JJ serum_NN as_IN complement_NN ,_, showed_VBD that_IN this_DT dissolved_JJ globulin_NN solution_NN contained_VBD active_JJ sensitizer_NN for_IN sheep_JJ RBCs_NNP ._.
The_DT filtrate_NN from_IN which_WDT the_DT globulins_NNS had_VBD been_VBN removed_VBN was_VBD dialysed_VBN in_IN run-_JJ ning_JJ water_NN and_CC a_DT little_JJ chloroform_NN was_VBD added_VBN to_TO it_PRP to_TO prevent_VB decomposition_NN ._.
After_IN removal_NN of_IN the_DT (_( NH4_NNP )_) 2SO4_CD the_DT tonicity_NN of_IN the_DT solution_NN was_VBD made_VBN to_TO equal_VB 0.85_CD per_IN cent_NN ._.
NaCl_NNP ,_, but_CC it_PRP had_VBD no_DT sensitizing_VBG effect_NN whatever_WDT on_IN sheep_JJ RBCs_NNP ;_: so_IN it_PRP is_VBZ evident_JJ that_IN the_DT whole_NN of_IN a_DT specific_JJ amboceptor_NN is_VBZ precipitated_VBN with_IN the_DT globulins_NNS of_IN a_DT serum_NN and_CC that_IN no_DT recognisable_JJ quantity_NN is_VBZ left_VBN in_IN the_DT albuminous_JJ filtrate_NN ._.
It_PRP was_VBD thought_VBN to_TO be_VB not_RB unlikely_JJ that_IN by_IN fractional_JJ precipitation_NN of_IN the_DT globulins_NNS the_DT amboceptor_NN might_MD be_VB obtained_VBN in_IN a_DT more_RBR concentrated_JJ state_NN ._.
94_CD cc_NN of_IN pony_JJ antisheep_JJ serum_NN were_VBD taken_VBN and_CC a_DT saturated_JJ solution_NN of_IN (_( NH4_NNP )_) 2SO4_CD was_VBD gradually_RB added_VBN till_IN the_DT serum_NN contained_VBD the_DT solution_NN in_IN 20_CD per_IN cent_NN ._.
concentration_NN ._.
The_DT precipitate_NN (_( A_DT )_) was_VBD filtered_VBN off_RP ,_, and_CC more_JJR (_( NH4_NNP )_) 2SO4_CD added_VBD to_TO the_DT filtrate_NN till_IN the_DT concentration_NN was_VBD 40_CD per_IN cent_NN ._.
Precipitate_NNP (_( B_NNP )_) was_VBD filtered_VBN off_RB and_CC the_DT concentration_NN of_IN the_DT filtrate_NN raised_VBD to_TO 50_CD per_IN cent_NN ._.
This_DT gave_VBD precipitate_NN (_( C_NNP )_) 10_CD The_DT precipitates_NNS were_VBD dissolved_VBN in_IN distilled_JJ water_NN ,_, reprecipitated_VBN by_IN similar_JJ concentrations_NNS of_IN (_( NH4_NNP )_) 2SO4_CD ,_, filtered_VBN ,_, re-dissolved_JJ in_IN distilled_JJ water_NN and_CC dialysed_VBD free_JJ from_IN salts_NNS ._.
They_PRP were_VBD then_RB dried_VBN in_IN vacuo_NN over_IN sulphuric_JJ acid_NN ,_, and_CC solutions_NNS were_VBD made_VBN up_RP from_IN each_DT with_IN 0.85_CD per_IN cent_NN ._.
NaCl_NNP corresponding_VBG in_IN volume_NN with_IN the_DT original_JJ bulk_NN of_IN serum_NN ._.
It_PRP is_VBZ always_RB difficult_JJ to_TO induce_VB globulins_NNS which_WDT have_VBP been_VBN thus_RB precipitated_VBN and_CC re-dissolved_JJ to_TO give_VB a_DT clear_JJ solution_NN in_IN the_DT end_NN ,_, but_CC a_DT preliminary_JJ experi-_JJ ment_NN with_IN another_DT portion_NN of_IN dried_JJ globulins_NNS had_VBD shown_VBN that_IN clear_JJ fluid_NN could_MD be_VB obtained_VBN by_IN filtration_NN through_IN paper_NN which_WDT did_VBD not_RB differ_VB demonstrably_RB in_IN amboceptoral_JJ content_NN from_IN the_DT turbid_NN liquid_NN ._.
It_PRP may_MD be_VB assumed_VBN ,_, therefore_RB ,_, that_IN the_DT amboceptoral_JJ molecules_NNS are_VBP more_RBR readily_RB soluble_JJ in_IN 0.85_CD per_IN cent_NN ._.
NaCl_NNP ._.
than_IN the_DT globulins_NNS with_IN which_WDT they_PRP are_VBP precipitated_VBN ._.
Series_NNS were_VBD then_RB put_VBN up_RP with_IN fluids_NNS A_NNP ,_, B_NNP and_CC C_NNP to_TO test_VB their_PRP$ relative_JJ amboceptoral_JJ powers_NNS on_IN sheep_JJ RBCs_NNP with_IN 0.2_CD cc_NNS guinea-pig_JJ complement_NN ._.
0.75_CD cc_NN Fluid_NNP A_NNP was_VBD required_VBN for_IN complete_JJ lysis_NN ._.
0.05_CD cc_JJ 11_CD We_PRP performed_VBD several_JJ experiments_NNS with_IN the_DT view_NN of_IN demonstrating_VBG the_DT passage_NN of_IN amboceptor_NN from_IN sensitized_VBN RBCs_NNP into_IN the_DT medium_NN of_IN suspension_NN ._.
Sheep_JJ RBCs_NNP were_VBD sensitized_VBN to_TO their_PRP$ limit_NN in_IN goat_NN antisheep_NN serum_NN ,_, washed_VBD and_CC suspended_VBD in_IN 0.85_CD per_IN cent_NN ._.
NaCl_NNP ._.
Whether_RB incubated_VBN at_IN 38°_CD C_NNP for_IN 2_CD hours_NNS and_CC tested_VBD immediately_RB ,_, or_CC kept_VB in_IN the_DT ice-box_NN for_IN 24_CD hours_NNS after_IN incubation_NN for_IN 4½_CD hours_NNS ,_, or_CC kept_VB in_IN the_DT ice-box_NN for_IN 24_CD hours_NNS without_IN previous_JJ incubation_NN ,_, no_DT amboceptor_NN could_MD ever_RB be_VB extracted_VBN by_IN fresh_JJ sheep_JJ RBCs_NN from_IN the_DT fluid_NN after_IN the_DT sensitized_JJ RBCs_NNP had_VBD been_VBN removed_VBN by_IN centrifugation_NN ,_, showing_VBG that_IN there_EX had_VBD been_VBN no_RB appreciable_JJ diffusion_NN and_CC that_IN the_DT amboceptor_NN originally_RB attached_VBN to_TO the_DT RBCs_NNP remained_VBD attached_VBN ._.
The_DT sensitized_JJ RBCs_NNP ,_, moreover_RB ,_, required_VBN precisely_RB the_DT same_JJ quantity_NN of_IN fresh_JJ sheep_JJ serum_NN as_IN complement_NN to_TO lyse_VB them_PRP ,_, after_IN being_VBG given_VBN every_DT opportunity_NN of_IN losing_VBG amboceptor_NN by_IN diffusion_NN ,_, as_IN was_VBD required_VBN by_IN another_DT portion_NN of_IN sensitized_VBN RBCs_NNP which_WDT had_VBD been_VBN tested_VBN at_IN once_RB ._.
For_IN this_DT reason_NN alone_VBD it_PRP must_MD be_VB considered_VBN that_IN the_DT union_NN of_IN RBC_NNP and_CC amboceptor_NN is_VBZ a_DT close_JJ one_CD ,_, and_CC that_IN a_DT state_NN of_IN equilibrium_NN between_IN corpuscles_NNS and_CC sensitizing_VBG fluid_NN as_IN regards_NNS amboceptor_NN does_VBZ not_RB exist_VB ._.
In_IN the_DT case_NN of_IN goat_NN RBCs_NNP obtained_VBD from_IN goat-antisheep-blood_NN ,_, which_WDT were_VBD washed_VBN and_CC incubated_VBN in_IN contact_NN with_IN an_DT equal_JJ quantity_NN of_IN sheep_JJ RBCs_NNP ,_, no_DT lysis_NN was_VBD obtained_VBN with_IN fresh_JJ sheep_NN serum_NN complement_NN ,_, showing_VBG that_IN no_DT transference_NN of_IN sensitizer_NN had_VBD occurred_VBN from_IN goat_NN RBCs_NNP to_TO sheep_VB RBCs_NNP in_IN appreciable_JJ quantity_NN ._.
It_PRP may_MD therefore_RB be_VB taken_VBN as_IN a_DT fact_NN the_DT RBCs_NNP of_IN an_DT immune_JJ serum_NN contain_VBP none_NN of_IN the_DT immune_JJ body_NN ._.
A_DT further_JJ experiment_NN shows_NNS that_WDT amboceptor_VBP ,_, far_RB from_IN being_VBG in_IN equilibrium_NN between_IN RBCs_NNP and_CC the_DT surrounding_VBG fluid_NN ,_, has_VBZ such_PDT a_DT powerful_JJ affinity_NN for_IN RBCs_NNP that_IN it_PRP can_MD be_VB extracted_VBN from_IN the_DT fluid_NN almost_RB completely_RB ,_, even_RB when_WRB the_DT latter_NN is_VBZ highly_RB diluted_VBN ._.
For_IN example_NN 1.5_CD cc_NN sheep_JJ RBCs_NNP were_VBD suspended_VBN in_IN 2_CD cc_NN of_IN goat-_JJ antisheep-serum_NN and_CC a_DT similar_JJ quantity_NN in_IN other_JJ 2_CD cc_NN of_IN the_DT same_JJ serum_NN diluted_VBN in_IN various_JJ degrees_NNS up_RB to_TO 1_CD in_IN 40_CD ._.
The_DT suspensions_NNS ,_, after_IN one_CD hour_NN in_IN the_DT incubator_NN with_IN one_CD or_CC two_CD shakings_NNS ,_, were_VBD centrifugated_VBN and_CC the_DT sensitized_JJ RBCs_NNP put_VBD up_RP with_IN fresh_JJ sheep_NN serum_NN complement_NN ._.
All_PDT the_DT series_NN showed_VBD precisely_RB the_DT same_JJ degree_NN of_IN lysis_NN ,_, showing_VBG that_IN the_DT affinity_NN between_IN RBCs_NNP and_CC sensitizer_NN in_IN the_DT case_NN of_IN immune_JJ serum_NN is_VBZ so_RB great_JJ that_IN for_IN experimental_JJ purposes_NNS it_PRP does_VBZ not_RB matter_VB whether_IN the_DT sensitizing-_JJ fluid_NN is_VBZ pure_JJ or_CC is_VBZ diluted_VBN with_IN 0.85_CD per_IN cent_NN ._.
NaCl_RB 40_CD times_NNS (_( in_IN another_DT experiment_NN 98_CD times_NNS )_) ;_: the_DT sensitizer_NN is_VBZ picked_VBN out_RP by_IN the_DT RBCs_NNP from_IN the_DT dilute_NN fluid_NN just_RB as_RB surely_RB as_IN from_IN the_DT pure_NN serum_NN ._.
Given_VBN high_JJ dilutions_NNS the_DT factor_NN of_IN time_NN would_MD doubtless_VB have_VB to_TO be_VB considered_VBN ;_: but_CC the_DT result_NN would_MD be_VB in_IN the_DT end_NN in_IN all_DT probability_NN the_DT same_JJ ._.
*_JJ *_NNP *_NNP *_NNP *_NNP (_( 7_CD )_) It_PRP is_VBZ generally_RB held_VBN that_IN complement_NN can_MD not_RB be_VB removed_VBN from_IN a_DT serum_NN by_IN RBCs_NNP unless_IN they_PRP have_VBP been_VBN previously_RB sensitized_VBN ._.
Sheep_JJ serum_NN does_VBZ not_RB lyse_VB dog_NN RBCs_NNP and_CC it_PRP follows_VBZ that_IN treatment_NN of_IN sheep_JJ serum_NN with_IN washed_JJ dog_NN RBCs_NNP will_MD not_RB result_VB in_IN abstraction_NN of_IN complement_NN ._.
5_CD cc_NN of_IN washed_JJ dog_NN RBCs_NNP were_VBD suspended_VBN in_IN 15_CD cc_NN fresh_JJ sheep_NN serum_NN and_CC the_DT tube_NN was_VBD incubated_VBN for_IN 1½_CD hours_NNS at_IN 37°_CD C._NNP No_NNP lysis_NN occurred_VBD ._.
After_IN centrifugation_NN the_DT treated_JJ sheep_NN serum_NN was_VBD put_VBN up_RP with_IN guinea-pig_JJ RBCs_NNP ,_, using_VBG as_IN a_DT control_NN another_DT portion_NN of_IN the_DT same_JJ serum_NN which_WDT had_VBD been_VBN incubated_VBN for_IN the_DT same_JJ time_NN ._.
Precisely_RB similar_JJ degrees_NNS of_IN lysis_NN followed_VBN in_IN both_DT the_DT series_NN showing_VBG that_IN no_DT complement_NN had_VBD been_VBN removed_VBN by_IN the_DT dog_NN RBCs_NNP ._.
To_TO test_VB whether_IN any_DT sensitization_NN had_VBD occurred_VBN in_IN the_DT dog_NN RBCs_NNP they_PRP were_VBD put_VBN up_RP with_IN fresh_JJ guinea-pig_JJ serum_NN as_IN complement_NN ._.
There_EX was_VBD no_DT lysis_NN ,_, so_IN it_PRP may_MD be_VB concluded_VBN that_IN there_EX had_VBD been_VBN no_DT sensitization_NN ._.
Even_RB when_WRB ._.
RBCs_NNP have_VBP been_VBN sensitized_VBN they_PRP do_VBP not_RB always_RB extract_VB complement_NN ._.
If_IN the_DT available_JJ complement_NN fits_VBZ the_DT sensitizer_NN it_PRP is_VBZ abstracted_VBN and_CC lysis_JJ occurs_NNS ;_: if_IN it_PRP does_VBZ not_RB fit_VB the_DT sensitizer_NN it_PRP is_VBZ not_RB abstracted_VBN and_CC there_EX is_VBZ no_DT lysis_NN ._.
Abstraction_NN of_IN complement_NN by_IN sensitized_JJ RBCs_NNP can_MD be_VB most_RBS clearly_RB demonstrated_VBN by_IN using_VBG heated_VBN RBCs_NNP (_( vide_JJ section_NN 2_CD ,_, p._RB 7_CD )_) for_IN the_DT subsequent_JJ tests_NNS are_VBP not_RB then_RB interfered_VBN with_IN by_IN B-I_NNP 12_CD a_DT fluid_NN coloured_VBN by_IN hæmoglobin_NN ._.
Thus_RB heated_VBN RBCs_NNP may_MD be_VB used_VBN to_TO extract_VB amboceptors_NNS from_IN different_JJ heated_VBN serums_NNS ,_, and_CC their_PRP$ sensitization_NN made_VBN evident_JJ by_IN their_PRP$ power_NN of_IN abstracting_VBG complement_NN from_IN other_JJ serums_NNS ._.
Whenever_WRB complement_NN is_VBZ thus_RB abstracted_VBN lysis_NN would_MD have_VB occurred_VBN if_IN the_DT RBCs_NNP had_VBD not_RB been_VBN heated_VBN ._.
Horse_NN serum_NN does_VBZ not_RB lyse_VB man_NN RBCs_NNP ._.
Sensitization_NN of_IN man_NN RBCs_NNP by_IN horse_NN serum_NN can_MD not_RB be_VB demonstrated_VBN ,_, and_CC so_RB horse_JJ serum_NN treated_VBN with_IN man_NN RBCs_NNP has_VBZ no_DT complement_NN abstracted_VBD from_IN it_PRP ._.
Horse_NN serum_NN does_VBZ ,_, however_RB ,_, lyse_JJ guinea-pig_JJ RBCs_NNP slightly_RB ,_, and_CC treatment_NN of_IN horse_NN serum_NN with_IN washed_JJ guinea-pig_JJ RBCs_NNP results_NNS in_IN slight_JJ lysis_NN ,_, and_CC the_DT consequent_JJ abstraction_NN of_IN complement_NN from_IN the_DT serum_NN can_MD easily_RB be_VB demonstrated_VBN ._.
*_JJ *_NNP *_NNP *_NNP *_NNP (_( 8_CD )_) There_EX seems_VBZ to_TO be_VB no_DT limit_NN to_TO the_DT number_NN of_IN amboceptors_NNS which_WDT can_MD be_VB present_JJ normally_RB in_IN a_DT serum_NN ,_, though_IN some_DT serums_NNS contain_VBP more_JJR ,_, some_DT less_RBR and_CC some_DT ,_, such_JJ as_IN horse_NN ,_, scarcely_RB any_DT at_IN all_DT ._.
For_IN example_NN we_PRP were_VBD able_JJ to_TO extract_VB from_IN the_DT same_JJ 20_CD cc_NN of_IN heated_JJ dog_NN serum_NN in_IN succession_NN the_DT following_JJ sensitizers_NNS :_: man_NN ,_, rabbit_NN ,_, guinea-pig_NN ,_, goat_NN ,_, sheep_NN ,_, horse_NN and_CC man_NN ,_, and_CC to_TO demonstrate_VB in_IN each_DT case_NN ,_, on_IN the_DT one_CD hand_NN ,_, the_DT sensitization_NN of_IN the_DT RBCs_NNP by_IN complementing_VBG with_IN fresh_JJ guinea-pig_JJ serum_NN and_CC ,_, on_IN the_DT other_JJ hand_NN ,_, the_DT absence_NN of_IN much_JJ more_JJR of_IN that_DT sensitizer_NN from_IN the_DT dog_NN serum_NN by_IN means_NNS of_IN the_DT addition_NN of_IN a_DT fresh_JJ portion_NN of_IN the_DT RBCs_NNP in_IN question_NN together_RB with_IN guinea-pig_JJ complement_NN ._.
Compared_VBN with_IN an_DT immune_JJ serum_NN ,_, which_WDT results_NNS from_IN the_DT injection_NN of_IN a_DT foreign_JJ serum_NN or_CC foreign_JJ RBCs_NNP ,_, a_DT normal_JJ serum_NN is_VBZ remarkably_RB deficient_JJ in_IN sensitizer_NN for_IN heterogenous_JJ RBCs_NNP ;_: but_CC there_EX is_VBZ great_JJ variation_NN among_IN individuals_NNS in_IN this_DT respect_NN ._.
As_IN a_DT general_JJ rule_NN a_DT normal_JJ serum_NN which_WDT is_VBZ potent_NN against_IN one_CD kind_NN of_IN RBCs_NNP is_VBZ potent_JJ against_IN all_DT ,_, and_CC one_CD which_WDT is_VBZ weak_JJ against_IN one_CD is_VBZ weak_JJ against_IN all_DT ;_: but_CC the_DT variations_NNS exhibited_VBN from_IN time_NN to_TO time_NN in_IN the_DT lytic_JJ power_NN of_IN a_DT serum_NN for_IN one_CD kind_NN of_IN RBCs_NNP are_VBP not_RB necessarily_RB accom-_JJ panied_VBN by_IN variations_NNS in_IN the_DT same_JJ direction_NN for_IN others_NNS ._.
Sheep_NNP serum_NN ,_, for_IN instance_NN ,_, which_WDT was_VBD largely_RB used_VBN in_IN the_DT course_NN of_IN numerous_JJ experiments_NNS for_IN several_JJ years_NNS ,_, was_VBD found_VBN to_TO vary_VB considerably_RB in_IN its_PRP$ relative_JJ lysin_NN content_NN for_IN the_DT seven_CD kinds_NNS of_IN RBCs_NNP generally_RB used_VBD ;_: that_DT is_VBZ to_TO say_VB ,_, if_IN the_DT quantity_NN of_IN lysin_JJ present_NN for_IN man_NN RBCs_NNP is_VBZ large_JJ ,_, it_PRP does_VBZ not_RB follow_VB that_IN the_DT lysin_NN for_IN rabbit_NN RBCs_NNP is_VBZ also_RB large_JJ ,_, and_CC vice_NN versâ_NN ._.
No_DT relation_NN can_MD be_VB made_VBN out_RP between_IN the_DT variations_NNS in_IN the_DT quantities_NNS of_IN the_DT different_JJ lysins_NNS from_IN time_NN to_TO time_NN ._.
Vide_NNP Chart_NNP No_NNP ._.
3_CD ._.
It_PRP may_MD be_VB that_DT plurality_NN of_IN amboceptors_NNS has_VBZ some_DT relation_NN to_TO diet_VB and_CC that_IN the_DT species_NNS whose_WP$ diet_JJ includes_VBZ the_DT widest_JJS range_NN of_IN proteins_NNS has_VBZ naturally_RB the_DT most_RBS diverse_JJ store_NN of_IN antibodies_NNS in_IN its_PRP$ blood_NN ._.
We_PRP thought_VBD it_PRP possible_JJ that_IN the_DT resistance_NN shown_VBN by_IN the_DT RBCs_NNP of_IN different_JJ species_NNS to_TO hypotonic_JJ lysis_NN might_MD be_VB related_VBN with_IN their_PRP$ resistance_NN to_TO lysis_VB by_IN normal_JJ serums_NNS ,_, but_CC the_DT large_JJ number_NN of_IN data_NNS collected_VBN do_VBP not_RB lend_VB support_NN to_TO this_DT view_NN ._.
Endeavours_NNS to_TO arrange_VB RBCs_NNP according_VBG to_TO their_PRP$ resistances_NNS to_TO coagulation_NN by_IN heat_NN failed_VBD ,_, as_IN mentioned_VBN before_IN ,_, owing_VBG to_TO time_NN not_RB permitting_VBG a_DT sufficiently_RB delicate_JJ method_NN of_IN measurement_NN being_VBG devised_VBN ,_, though_IN there_EX were_VBD certainly_RB indications_NNS that_IN this_DT order_NN corresponded_VBD in_IN some_DT degree_NN with_IN their_PRP$ resistance_NN to_TO hypotonic_JJ lysis_NN ._.
A_DT number_NN of_IN experiments_NNS made_VBN it_PRP seem_VBP probable_JJ that_IN some_DT relation_NN also_RB exists_VBZ between_IN the_DT specific_JJ gravity_NN of_IN RBCs_NNP and_CC their_PRP$ resistance_NN to_TO hypotonic_JJ lysis_NN ,_, though_RB here_RB again_RB we_PRP failed_VBD to_TO elaborate_VB a_DT method_NN of_IN sufficient_JJ accuracy_NN in_IN the_DT time_NN which_WDT could_MD be_VB devoted_VBN to_TO it_PRP ._.
The_DT specific_JJ gravity_NN as_IN determinedTo_JJ face_NN page_NN 12_CD CHART_NNP No_NNP ._.
3_CD Showing_VBG the_DT variations_NNS in_IN the_DT lysin_NN content_NN of_IN the_DT serum_NN of_IN a_DT normal_JJ sheep_NN for_IN the_DT R_NNP B_NNP Cs_NNP of_IN Horse_NNP ,_, Man_NNP and_CC Rabbit_NNP from_IN April_NNP 4th_CD to_TO July_NNP 1st_CD 1910_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 74918151.tif_CD ]_JJ S.O_NNP ._.
1911_CD Reg_NNP :_: No_DT ._.
1260_CD ._.
Copies_NNS 13_CD Horse_NNP 1.75_CD Rabbit_NNP 1.83_CD Guinea-pig_NNP 2.41_CD Man_NNP 2.48_CD (_( cf_NN ._.
list_NN on_IN p_NN ._.
5_CD ._. )_)
Specific_JJ gravity_NN ,_, coagulation_NN by_IN heat_NN and_CC hypotonic_JJ lysis_NN are_VBP ,_, however_RB ,_, all_DT concerned_VBN with_IN the_DT physical_JJ conformation_NN of_IN RBCs_NNP ,_, whereas_JJ serum_NN lysis_NN is_VBZ a_DT chemical_JJ reaction_NN ;_: and_CC there_EX is_VBZ no_DT obvious_JJ indication_NN that_IN there_EX should_MD be_VB any_DT relation_NN between_IN physical_JJ characters_NNS such_JJ as_IN these_DT and_CC chemical_NN composition_NN ._.
To_TO return_VB to_TO the_DT action_NN of_IN normal_JJ serums_NNS on_IN washed_JJ RBCs_NNP :_: of_IN the_DT eight_CD tested_VBN (_( serum_NN from_IN 20_CD individuals_NNS of_IN each_DT species_NNS )_) ,_, dog_JJ serum_NN was_VBD unquestionably_RB the_DT most_RBS potent_JJ ,_, horse_NN easily_RB last_JJ and_CC guinea-pig_JJ last_JJ but_CC one_CD ._.
A_DT peculiar_JJ feature_NN of_IN these_DT experiments_NNS was_VBD the_DT appearance_NN with_IN considerable_JJ frequency_NN of_IN natural_JJ deviation_NN of_IN complement_NN ,_, a_DT phenomenon_NN which_WDT we_PRP believe_VBP has_VBZ not_RB been_VBN recorded_VBN before_IN ._.
A_DT series_NN of_IN tubes_NNS ,_, each_DT containing_VBG 0.05_CD cm_NN ._.
RBCs_NNP and_CC altogether_RB 2_CD cc_NN ._.
of_IN fluid_NN ,_, with_IN serum_NN in_IN percentages_NNS descending_VBG from_IN 100_CD to_TO 2.5_CD would_MD show_VB ``_`` partial_JJ ''_'' and_CC ``_`` not_RB complete_JJ ''_'' lysis_NN in_IN the_DT tubes_NNS containing_VBG from_IN 100_CD per_IN cent_NN to_TO 60_CD per_IN cent_NN ._.
serum_NN ,_, ``_`` complete_JJ ''_'' lysis_NN from_IN 60_CD per_IN cent.14_NN TABLE_NNP No_NNP ._.
4_CD ._.
15_CD Taking_VBG Table_JJ 4_CD as_IN it_PRP stands_VBZ ,_, the_DT order_NN of_IN potency_NN of_IN the_DT eight_CD normal_JJ serums_NNS is_VBZ as_IN follows:16_NN valid_JJ reason_NN why_WRB it_PRP should_MD not_RB be_VB so_RB for_IN natural_JJ amboceptors_NNS also_RB ._.
On_IN the_DT other_JJ hand_NN the_DT method_NN will_MD give_VB indications_NNS ,_, for_IN instance_NN in_IN the_DT case_NN of_IN horse_NN serum_NN ._.
Fresh_JJ horse_NN serum_NN by_IN itself_PRP will_MD not_RB lyse_VB man_NN RBCs_NNP and_CC has_VBZ only_RB a_DT slight_JJ action_NN on_IN guinea-pig_JJ RBCs_NNP ,_, but_CC when_WRB these_DT RBCs_NNP ,_, are_VBP sensitized_VBN in_IN heated_JJ horse_NN serum_NN ,_, 74_CD parts_NNS serum_NN to_TO i_VB part_NN RBCs_NNP ,_, lysis_NN of_IN both_DT is_VBZ obtained_VBN with_IN guinea-pig_JJ complement_NN ,_, showing_VBG that_IN horse_NN serum_NN contains_VBZ some_DT sensitizer_NN for_IN man_NN RBCs_NNP as_RB well_RB as_IN for_IN guinea-pig_JJ RBCs_NNP but_CC that_IN horse_NN complement_NN for_IN some_DT reason_NN does_VBZ not_RB lyse_VB the_DT former_JJ ._.
Experiments_NNS were_VBD made_VBN to_TO determine_VB whether_IN better_JJR results_NNS were_VBD obtained_VBN by_IN previous_JJ sensitization_NN of_IN RBCs_NNP in_IN a_DT heated_JJ immune_NN serum_NN ,_, before_IN adding_VBG them_PRP to_TO the_DT lytic_JJ mixture_NN ,_, than_IN by_IN adding_VBG the_DT immune_NN serum_VBZ directly_RB to_TO the_DT mixture_NN ._.
To_TO secure_VB exactly_RB comparable_JJ quantitative_JJ results_NNS is_VBZ by_IN no_DT means_NNS a_DT simple_JJ matter_NN ._.
It_PRP is_VBZ probable_JJ that_IN amboceptor_NN is_VBZ absorbed_VBN by_IN sensitive_JJ RBCs_NNP at_IN a_DT rate_NN inversely_RB proportional_JJ to_TO its_PRP$ concentration_NN in_IN the_DT RBCs_NNP and_CC ,_, therefore_RB ,_, it_PRP takes_VBZ an_DT infinite_JJ time_NN for_IN a_DT serum_NN to_TO be_VB entirely_RB freed_VBN from_IN sensitizer_NN ._.
It_PRP is_VBZ likewise_RBR probable_JJ that_IN ,_, if_IN amboceptor_NN is_VBZ available_JJ in_IN a_DT hæmolytic_JJ system_NN ,_, the_DT avidity_NN of_IN the_DT RBC_NNP substance_NN for_IN it_PRP varies_VBZ with_IN the_DT amount_NN of_IN union_NN with_IN complement_NN which_WDT has_VBZ taken_VBN place_NN ,_, i.e._FW ,_, if_IN a_DT molecule_NN of_IN amboceptor_NN has_VBZ been_VBN put_VBN out_IN of_IN action_NN by_IN union_NN with_IN RBC_NNP and_CC complement_NN ,_, the_DT remainder_NN of_IN that_DT RBC_NNP will_MD be_VB more_RBR avid_JJ of_IN amboceptor_NN than_IN it_PRP would_MD have_VB been_VBN if_IN merely_RB the_DT union_NN of_IN an_DT amboceptor_NN molecule_NN had_VBD taken_VBN place_NN in_IN the_DT absence_NN of_IN complement_NN ._.
Hence_NN it_PRP is_VBZ possible_JJ that_IN ,_, even_RB when_WRB equivalent_JJ proportions_NNS of_IN RBCs_NNP and_CC sensitizer_NN are_VBP used_VBN ,_, there_EX will_MD be_VB more_RBR amboceptor_JJ available_JJ for_IN the_DT RBCs_NNP if_IN the_DT immune_NN serum_NN be_VB present_JJ in_IN the_DT system_NN than_IN if_IN the_DT RBCs_NNP had_VBD had_VBN to_TO fix_VB all_PDT the_DT sensitizer_NN they_PRP could_MD within_IN a_DT limited_JJ time_NN from_IN a_DT similar_JJ quantity_NN of_IN serum_NN ._.
On_IN incubation_NN of_IN two_CD such_JJ series_NN lysis_NN occurs_VBZ much_RB more_RBR rapidly_RB in_IN the_DT RBCs_NNP already_RB sensitized_VBD for_IN the_DT reason_NN that_WDT half_PDT the_DT reaction_NN ,_, that_WDT is_VBZ union_NN of_IN amboceptor_NN ,_, has_VBZ already_RB taken_VBN place_NN ,_, but_CC the_DT final_JJ results_NNS are_VBP very_RB much_RB the_DT same_JJ ._.
The_DT differences_NNS noted_VBD in_IN our_PRP$ experiments_NNS were_VBD so_RB small_JJ and_CC inconstant_JJ that_IN they_PRP are_VBP attributed_VBN to_TO error_VB ._.
*_JJ *_NNP *_NNP *_NNP *_NNP (_( 10_CD )_) Bordet_NNP several_JJ years_NNS ago_RB showed_VBD that_IN when_WRB amboceptor_NN is_VBZ in_IN excess_JJ RBCs_NNP can_MD absorb_VB more_JJR than_IN they_PRP actually_RB require_VBP for_IN complete_JJ lysis_NN with_IN the_DT minimum_JJ active_JJ dose_NN of_IN complement_NN ,_, and_CC that_IN a_DT given_VBN quantity_NN of_IN serum_NN will_MD lyse_VB more_RBR RBCs_NNP when_WRB they_PRP are_VBP added_VBN simultaneously_RB than_IN when_WRB they_PRP are_VBP added_VBN in_IN successive_JJ amounts_NNS ._.
As_IN deviation_NN could_MD not_RB be_VB demonstrated_VBN in_IN the_DT ordinary_JJ way_NN with_IN sheep_JJ RBCs_NNP sensitized_VBD in_IN our_PRP$ Goat_NNP B_NNP antisheep_NN serum_NN ,_, we_PRP desired_VBD to_TO find_VB whether_IN the_DT above_JJ held_VBD good_JJ in_IN this_DT particular_JJ case_NN ._.
It_PRP proved_VBD that_IN when_WRB the_DT sheep_NN RBCs_NNP were_VBD added_VBN altogether_RB the_DT time_NN required_VBN for_IN complete_JJ lysis_NN was_VBD immensely_RB pro-_JJ longed_VBD when_WRB the_DT quantity_NN of_IN RBCs_NNP was_VBD doubled_VBN ._.
Fresh_NNP Goat_NNP B_NNP serum_VBD 1.0_CD 1.0_CD 1.0_CD Sheep_NNP RBCs_NNP 0.4_CD 0.6_CD 0.8_CD Time_NN required_VBN for_IN complete_JJ lysis_NN in_IN minutes_NNS 6_CD '_POS 17_CD '_POS 53_CD '_NNS but_CC when_WRB the_DT sheep_NN RBCs_NNP were_VBD added_VBN 0.2_CD cc_NN at_IN a_DT time_NN to_TO the_DT same_JJ quantity_NN of_IN serum_NN ,_, waiting_VBG for_IN complete_JJ lysis_NN of_IN each_DT lot_NN before_IN the_DT addition_NN of_IN the_DT next_JJ ,_, the_DT lysin_NN was_VBD soon_RB exhausted_VBN ._.
Fresh_NNP Goat_NNP B_NNP serum_VBD 1.0_CD Sheep_NNP RBCs_NNP 0.2_CD 0.2_CD 0.2_CD Time_NN required_VBN for_IN complete_JJ lysis_NN in_IN minutes_NNS 4_CD '_POS 43_CD '_POS 3_CD hours_NNS not_RB complete_JJ ._.
17_CD so_RB I_PRP cc_VBP ._.
fresh_JJ B_NNP serum_NN dissolved_VBD 0.4_CD cc_NN ._.
sheep_JJ RBCs_NNP added_VBD at_IN once_RB ,_, completely_RB in_IN 618_CD 3_CD ._.
On_IN the_DT Ponderability_NNP of_IN Amboceptor_NNP ._.
Having_VBG noticed_VBN that_IN sensitized_JJ RBCs_NNP are_VBP more_RBR quickly_RB sedimented_VBN by_IN centrifugation_NN than_IN unsensitized_JJ ones_NNS and_CC that_IN this_DT holds_VBZ good_JJ ,_, though_RB in_IN a_DT lesser_JJR degree_NN ,_, even_RB when_WRB the_DT RBCs_NNP are_VBP not_RB visibly_RB agglutinated_VBN during_IN the_DT process_NN of_IN sensitization_NN ,_, it_PRP seemed_VBD by_IN no_DT means_NNS unlikely_RB that_IN it_PRP would_MD be_VB possible_JJ to_TO show_VB by_IN means_NNS of_IN the_DT balance_NN an_DT increase_NN of_IN weight_NN following_VBG sensitization_NN ._.
Addition_NN of_IN matter_NN to_TO the_DT RBCs_NNP must_MD be_VB accompanied_VBN by_IN an_DT equivalent_JJ loss_NN from_IN the_DT sensitizing_VBG serum_NN ._.
Of_IN several_JJ methods_NNS attempted_VBD the_DT following_NN seemed_VBD to_TO give_VB room_NN for_IN least_JJS experimental_JJ error_NN and_CC were_VBD attended_VBN with_IN fairly_RB satisfactory_JJ results:19_NN 4_CD ._.
Isolysins_NNS ._.
Goat_NNP B_NNP which_WDT had_VBD been_VBN injected_VBN at_IN intervals_NNS for_IN the_DT past_JJ three_CD years_NNS with_IN citrated_JJ sheep_JJ blood_NN was_VBD found_VBN to_TO have_VB developed_VBN an_DT isolysin_NN in_IN its_PRP$ serum_NN which_WDT lysed_VBD the_DT RBCs_NNP of_IN all_PDT the_DT different_JJ goats_NNS tested_VBD ,_, with_IN the_DT aid_NN of_IN guinea-pig_NN ._.
complement_NN ._.
Its_PRP$ own_JJ RBCs_NNP alone_RB remained_VBD intact_JJ ._.
This_DT amboceptor_NN could_MD not_RB be_VB complemented_VBN by_IN either_DT fresh_JJ sheep_NN or_CC fresh_JJ goat_NN serum_NN ._.
Horse_NN serum_NN however_RB complemented_VBD it_PRP slightly_RB ._.
There_EX was_VBD some_DT difference_NN noticed_VBD between_IN the_DT degree_NN of_IN lysis_NN obtained_VBN with_IN the_DT RBCs_NNP of_IN different_JJ goats_NNS with_IN this_DT isolysin_NN and_CC guinea-pig_JJ complement_NN ,_, and_CC this_DT difference_NN was_VBD even_RB more_JJR marked_JJ with_IN horse_NN complement_NN ._.
Evidently_RB there_EX was_VBD a_DT difference_NN between_IN the_DT RBCs_NNP of_IN different_JJ individuals_NNS as_IN regards_NNS their_PRP$ ability_NN to_TO absorb_VB this_DT amboceptor_NN ;_: and_CC the_DT fact_NN that_IN Goat_NNP B_NNP 's_POS own_JJ RBCs_NNP were_VBD not_RB able_JJ to_TO absorb_VB it_PRP at_IN all_DT renders_NNS it_PRP certain_JJ that_IN the_DT RBCs_NNP of_IN individuals_NNS of_IN the_DT same_JJ species_NNS are_VBP not_RB exactly_RB alike_RB in_IN their_PRP$ reactions_NNS with_IN lyric_JJ agents_NNS ._.
With_IN heterolysins_NNS this_DT fact_NN has_VBZ not_RB been_VBN recorded_VBN :_: it_PRP is_VBZ possible_JJ that_IN a_DT goat_NN injected_VBN with_IN sheep_JJ RBCs_NNP from_IN one_CD sheep_NN only_RB would_MD not_RB develop_VB a_DT lysin_JJ potent_NN against_IN the_DT RBCs_NNP of_IN all_DT other_JJ sheep_NN ,_, but_CC only_RB against_IN a_DT certain_JJ number_NN ._.
Todd_NNP and_CC White_NNP ,_, (_( Proc_NNP ._.
Roy_NNP ._.
Soc._NNP ,_, B._NNP ,_, Vol_NNP ._.
82_CD ,_, p._NN 416_CD ,_, 1910_CD )_) with_IN the_DT unique_JJ material_NN at_IN their_PRP$ disposal_NN ,_, have_VBP shown_VBN that_IN isolysins_NNS are_VBP developed_VBN in_IN the_DT serum_NN of_IN cattle_NNS which_WDT have_VBP been_VBN injected_VBN with_IN the_DT blood_NN of_IN other_JJ cattle_NNS ,_, and_CC that_IN these_DT isolysins_NNS are_VBP effective_JJ against_IN only_RB a_DT certain_JJ proportion_NN of_IN the_DT RBCs_NNP of_IN other_JJ individuals_NNS ._.
By_IN mixing_VBG the_DT serums_NNS of_IN these_DT immunised_VBN cattle_NNS they_PRP were_VBD able_JJ to_TO obtain_VB an_DT isolysin_JJ potent_NN against_IN the_DT RBCs_NNP of_IN all_PDT the_DT cattle_NNS tested_VBD ._.
They_PRP do_VBP not_RB definitely_RB state_NN whether_IN the_DT inoculations_NNS each_DT animal_NN received_VBN were_VBD derived_VBN from_IN one_CD animal_NN only_RB ,_, but_CC presumably_RB this_DT was_VBD not_RB so_RB ._.
As_IN in_IN the_DT case_NN of_IN our_PRP$ goat_NN ,_, whose_WP$ isolysin_NN can_MD not_RB be_VB complemented_VBN by_IN goat_NN serum_NN ,_, Todd_NNP and_CC White_NNP 's_POS isolysins_NNS could_MD not_RB be_VB comple-_JJ mented_VBN by_IN ox_NN serum_NN ,_, but_CC were_VBD well_RB complemented_VBN by_IN guinea-pig_JJ serum_NN ;_: nor_CC was_VBD any_DT isolysin_JJ effective_JJ against_IN the_DT RBCs_NNP of_IN the_DT individual_NN from_IN which_WDT it_PRP was_VBD derived_VBN ._.
There_EX is_VBZ a_DT distinction_NN between_IN Todd_NNP and_CC White_NNP 's_POS isolysins_NNS and_CC ours_NNS in_IN that_DT theirs_EX were_VBD the_DT result_NN of_IN the_DT inoculation_NN of_IN cattle_JJ blood_NN into_IN cattle_NNS ,_, irrespective_JJ ,_, it_PRP is_VBZ true_JJ ,_, of_IN breed_NN ,_, whereas_JJ ours_NN was_VBD the_DT result_NN of_IN the_DT inoculation_NN of_IN a_DT goat_NN with_IN sheep_JJ blood_NN ._.
Evidently_RB the_DT goat_NN and_CC sheep_NN are_VBP so_RB nearly_RB allied_JJ and_CC so_RB little_JJ difference_NN exists_NNS between_IN the_DT composition_NN of_IN their_PRP$ RBCs_NNP that_IN injection_NN of_IN the_DT RBCs_NNP of_IN one_CD induce_NN the_DT formation_NN of_IN a_DT specific_JJ lysin_NN for_IN both_DT ._.
Todd_NNP and_CC White_NNP 's_POS isolysins_NNS were_VBD effective_JJ also_RB against_IN goat_NN RBCs_NNP ._.
Sheep_NNP and_CC horse_NN apparently_RB were_VBD not_RB tested_VBN ._.
When_WRB the_DT heated_VBN serum_NN of_IN our_PRP$ goat_NN was_VBD treated_VBN with_IN goat_NN RBCs_NNP only_RB the_DT specific_JJ goat_NN isolysin_NN was_VBD extracted_VBN ,_, leaving_VBG the_DT specific_JJ sheep_JJ heterolysin_NN intact_JJ ,_, but_CC when_WRB treated_VBN with_IN sheep_JJ RBCs_NNP both_DT lysins_NNS were_VBD extracted_VBN and_CC the_DT serum_NN no_RB longer_RBR was_VBD able_JJ to_TO sensitize_VB goat_NN RBCs_NNP ._.
Homogenous_JJ RBCs_NNP therefore_NN ,_, do_VBP not_RB extract_VB a_DT specific_JJ lysin_NN ,_, but_CC the_DT heterogenous_JJ RBCs_NNP for_IN which_WDT the_DT lysin_NN is_VBZ specific_JJ extract_JJ both_CC the_DT specific_JJ lysin_NN and_CC the_DT isolysin_NN ._.
In_IN addition_NN to_TO the_DT goat_NN isolysin_NN Goat_NNP B_NNP had_VBD also_RB developed_VBN a_DT slight_JJ amount_NN of_IN lysin_NN for_IN horse_NN RBCs_NNP ,_, which_WDT was_VBD complemented_VBN by_IN guinea-pig_JJ serum_NN ,_, but_CC not_RB by_IN sheep_NN ,_, goat_NN or_CC horse_NN serums_NNS ._.
This_DT goat_NN ,_, as_IN stated_VBN before_IN ,_, had_VBD been_VBN strongly_RB immunised_VBN against_IN sheep_JJ RBCs_NNP for_IN a_DT period_NN of_IN three_CD years_NNS ._.
A_DT less_RBR strongly_RB immunised_VBN goat_NN developed_VBD no_DT isolysin_NN ,_, and_CC a_DT horse_NN which_WDT had_VBD been_VBN treated_VBN with_IN sheep_JJ blood_NN for_IN about_RB nine_CD months_NNS developed_VBN no_DT horse_NN isolysin_NN and_CC only_RB a_DT poor_JJ goat_NN heterolysin_NN ;_: so_CC it_PRP appears_VBZ that_IN isolysins_NNS are_VBP not_RB as_IN easily_RB or_CC as_IN quickly_RB formed_VBN as_IN heterolysins_NNS ._.
The_DT formation_NN of_IN the_DT horse_NN heterolysin_NN in_IN Goat_NNP B_NNP indicates_VBZ a_DT comparatively_RB close_JJ relationship_NN between_IN the_DT horse_NN and_CC the_DT sheep_NN ,_, and_CC it_PRP is_VBZ possible_JJ that_IN a_DT prolongation_NN of_IN the_DT period_NN of_IN immunisation_NN would_MD induce_VB the_DT formation_NN of_IN a_DT greater_JJR quantity_NN of_IN the_DT sensitizer_NN for_IN horse_NN RBCs_NNP ._.
Ehrlich_NNP several_JJ years_NNS ago_RB recorded_VBD the_DT formation_NN of_IN isolysins_NNS in_IN goats_NNS which_WDT had_VBD been_VBN injected_VBN with_IN goat_NN blood_NN ,_, and_CC showed_VBD that_IN these_DT isolysins_NNS also_RB lysed_VBD sheep_JJ RBCs_NNP ._.
He_PRP obtained_VBD isolysins_NNS of_IN various_JJ kinds_NNS ,_, some_DT effective_JJ against_IN the_DT RBCs_NNP of_IN one_CD group_NN of_IN goats_NNS but_CC not_RB of_IN another_DT ,_, others_NNS C-I_VBP 20_CD effective_JJ against_IN the_DT RBCs_NNP of_IN some_DT out_IN of_IN each_DT these_DT groups_NNS ._.
Some_DT of_IN his_PRP$ isolysins_NNS dissolved_VBD sheep_JJ RBCs_NNP ,_, some_DT did_VBD not_RB ._.
Again_NNP ,_, some_DT goats_NNS did_VBD not_RB develop_VB an_DT isolysin_NN at_IN all_DT ._.
His_PRP$ isolysins_NNS ,_, however_RB ,_, were_VBD all_DT tested_VBN directly_RB and_CC not_RB with_IN the_DT aid_NN of_IN guinea-pig_JJ complement_NN ._.
The_DT serum_NN of_IN a_DT pony_NN which_WDT we_PRP have_VBP injected_VBN with_IN sheep_JJ blood_NN for_IN a_DT year_NN now_RB lyses_VBZ goat_NN RBCs_NNP readily_RB ,_, but_CC it_PRP contains_VBZ no_DT isolysin_NN for_IN horse_NN RBCs_NNP ._.
It_PRP seems_VBZ clear_JJ that_IN the_DT RBCs_NNP of_IN any_DT one_CD species_NNS contain_VBP some_DT substances_NNS in_IN common_JJ with_IN the_DT RBCs_NNP of_IN nearly_RB allied_JJ species_NNS ,_, so_IN that_IN the_DT injection_NN of_IN the_DT RBCs_NNP of_IN that_DT species_VBZ into_IN an_DT animal_NN of_IN another_DT species_NNS gives_VBZ rise_NN to_TO the_DT formation_NN of_IN immune_JJ bodies_NNS against_IN each_DT of_IN those_DT substances_NNS ._.
Judging_VBG by_IN the_DT length_NN of_IN time_NN required_VBN for_IN the_DT formation_NN of_IN isolysins_NNS ,_, comparatively_RB speaking_VBG ,_, the_DT amount_NN of_IN these_DT common_JJ substances_NNS must_MD be_VB relatively_RB small_JJ ._.
It_PRP is_VBZ also_RB clear_JJ that_IN the_DT RBCs_NNP of_IN individuals_NNS are_VBP not_RB of_IN exactly_RB similar_JJ com-_JJ position_NN ,_, since_IN isolysins_NNS are_VBP not_RB uniformly_RB active_JJ against_IN the_DT RBCs_NNP of_IN all_DT indi-_JJ viduals_NNS ._.
Indeed_RB ,_, if_IN an_DT isolysin_NN is_VBZ totally_RB inactive_JJ against_IN the_DT RBCs_NNP of_IN some_DT one_CD individual_NN ,_, one_CD can_MD only_RB assume_VB that_IN the_DT structure_NN of_IN that_DT individual_NN 's_POS RBCs_NNP is_VBZ entirely_RB different_JJ from_IN the_DT structure_NN of_IN the_DT RBCs_NNP with_IN which_WDT the_DT animal_NN providing_VBG the_DT isolysin_NN was_VBD immunised_VBN ._.
Todd_NNP and_CC White_NNP found_VBD that_IN by_IN mixing_VBG their_PRP$ serums_NNS they_PRP obtained_VBD an_DT isolysin_NN which_WDT was_VBD universally_RB potent_JJ ._.
Our_PRP$ Goat_NNP B_NNP ,_, which_WDT has_VBZ been_VBN injected_VBN with_IN the_DT blood_NN of_IN a_DT different_JJ sheep_NN on_IN each_DT occasion_NN during_IN the_DT three_CD years_NNS ,_, has_VBZ probably_RB had_VBD a_DT sample_NN of_IN most_JJS of_IN the_DT possible_JJ varieties_NNS of_IN sheep_JJ RBCs_NNP ._.
It_PRP has_VBZ not_RB failed_VBN to_TO lyse_VB the_DT RBCs_NNP of_IN any_DT goat_NN which_WDT has_VBZ been_VBN tested_VBN ,_, except_IN its_PRP$ own_JJ ,_, so_IN that_IN with_IN the_DT RBCs_NNP from_IN a_DT large_JJ number_NN of_IN different_JJ sheep_NN it_PRP has_VBZ prob-_NN ably_RB also_RB received_VBD most_JJS of_IN the_DT possible_JJ varieties_NNS of_IN the_DT substance_NN common_JJ to_TO sheep_VB and_CC goat_VB RBCs_NNP ,_, and_CC is_VBZ ,_, therefore_RB ,_, probably_RB universally_RB potent_JJ against_IN goat_NN RBCs_NNP ,_, though_RB ,_, as_IN we_PRP demonstrated_VBD ,_, not_RB in_IN equal_JJ degree_NN in_IN every_DT case_NN ._.
Why_WRB does_VBZ this_DT difference_NN exist_NN in_IN the_DT potency_NN of_IN isolysins_NNS against_IN the_DT RBCs_NNP of_IN different_JJ individuals_NNS when_WRB it_PRP has_VBZ never_RB been_VBN recorded_VBN that_IN a_DT specific_JJ heterolysin_NN has_VBZ failed_VBN against_IN the_DT RBCs_NNP of_IN any_DT one_CD individual_NN ?_.
Might_NNP it_PRP happen_VBD that_IN the_DT serum_NN of_IN a_DT horse_NN immunised_VBN against_IN sheep_JJ RBCs_NNP would_MD fail_VB against_IN the_DT RBCs_NNP of_IN certain_JJ sheep_NN ,_, if_IN the_DT blood_NN used_VBN for_IN immunisation_NN on_IN each_DT occasion_NN had_VBD been_VBN obtained_VBN from_IN the_DT same_JJ sheep_NN ;_: or_CC without_IN complete_JJ failure_NN is_VBZ there_RB a_DT recognisable_JJ difference_NN in_IN the_DT degree_NN of_IN lysis_NN obtained_VBN with_IN RBCs_NNP from_IN various_JJ individuals_NNS ?_.
Answers_NNS to_TO these_DT questions_NNS can_MD not_RB as_IN yet_RB be_VB given_VBN ,_, nor_CC can_MD a_DT clear_JJ explanation_NN be_VB put_VBN forward_RB to_TO account_VB for_IN the_DT escape_NN from_IN autolysis_NN of_IN the_DT RBCs_NNP of_IN the_DT animal_NN furnishing_VBG the_DT isolysin_NN ,_, unless_IN we_PRP postulate_VBP the_DT simultaneous_JJ production_NN of_IN anti-_JJ autolysin_NN ._.
In_IN the_DT cases_NNS of_IN our_PRP$ Goat_NNP B_NNP and_CC Todd_NNP and_CC White_NNP 's_POS cattle_NNS the_DT isolysins_NNS were_VBD not_RB able_JJ to_TO be_VB complemented_VBN except_IN by_IN guinea-pig_JJ serum_NN ._.
Ehrlich_NNP 's_POS isolytic_JJ serums_NNS apparently_RB sufficed_VBN in_IN themselves_PRP without_IN a_DT heterogenous_JJ complement_NN ._.
It_PRP is_VBZ conceivable_JJ that_IN the_DT specificity_NN of_IN artificially_RB produced_VBN lytic_JJ serums_NNS is_VBZ relative_JJ only.If_IN one_CD injects_VBZ a_DT goat_NN with_IN sheep_JJ RBCs_NNP ,_, first_RB a_DT sheep_JJ heterolysin_NN is_VBZ formed_VBN ;_: then_RB gradually_RB a_DT goat_NN isolysin_NN ,_, which_WDT increases_VBZ its_PRP$ range_NN over_IN individual_JJ goats_NNS as_IN the_DT number_NN of_IN individual_JJ sheep_NN providing_VBG RBCs_NNP for_IN injection_NN is_VBZ multi-_JJ plied_NNS ._.
Thirdly_RB ,_, a_DT horse_NN heterolysin_NN appears_VBZ ._.
Supposing_VBG that_IN it_PRP were_VBD practicable_JJ to_TO inject_VB a_DT goat_NN with_IN RBCs_NNP from_IN an_DT infinite_JJ number_NN of_IN sheep_NN ,_, a_DT sufficient_JJ variety_NN of_IN substances_NNS ,_, proceeding_VBG from_IN an_DT infinite_JJ number_NN of_IN varying_VBG RBCs_NNP ,_, might_MD be_VB injected_VBN to_TO produce_VB lysins_NNS for_IN the_DT RBCs_NNP of_IN other_JJ less_JJR nearly_RB allied_JJ animals_NNS ,_, per-_JJ haps_NNS for_IN all_DT orders_NNS ._.
5_CD ._.
Some_DT Facts_NNS relating_VBG to_TO Complement_NNP ._.
(_( I_PRP )_) Lability_NN of_IN complement21_NN which_WDT has_VBZ been_VBN allowed_VBN to_TO clot_VB ,_, when_WRB the_DT defibrinated_VBN serum_NN is_VBZ used_VBN immediately_RB it_PRP can_MD be_VB prepared_VBN and_CC the_DT serum_NN from_IN the_DT clot_NN directly_RB a_DT sufficient_JJ quantity_NN has_VBZ sepa-_RB rated_VBN ._.
Serum_NNP which_WDT is_VBZ obtained_VBN from_IN blood_NN drawn_VBN the_DT previous_JJ day_NN and_CC allowed_VBN to_TO clot_VB ,_, even_RB though_IN kept_VBN in_IN the_DT ice_NN box_NN in_IN the_DT interval_NN ,_, is_VBZ generally_RB found_VBN to_TO be_VB less_RBR potent_JJ than_IN serum_NN obtained_VBN from_IN defibrinated_VBN blood_NN and_CC used_VBD immediately_RB ._.
The_DT loss_NN of_IN lytic_JJ power_NN is_VBZ not_RB ,_, however_RB ,_, necessarily_RB proportionate_VB for_IN all_DT kinds_NNS of_IN RBCs_NNP that_WDT may_MD be_VB tested_VBN ._.
The_DT following_VBG table_NN shows_VBZ the_DT relative_JJ amounts_NNS of_IN lysis_NN in_IN one_CD experiment:22_NN *_NNP *_NNP *_NNP *_NNP *_NNP (_( 3_CD )_) Possessing_VBG three_CD animals_NNS ,_, which_WDT had_VBD been_VBN immunised_VBN against_IN sheep_JJ RBCs_NNP by_IN repeated_JJ injections_NNS ,_, experiments_NNS were_VBD made_VBN to_TO determine_VB the_DT relative_JJ values_NNS of_IN various_JJ complements_NNS with_IN these_DT three_CD amboceptors_NNS ._.
The_DT animals_NNS immunised_VBN were_VBD Goat_NNP B_NNP ,_, Goat_NNP K_NNP and_CC a_DT country_NN bred_VBD pony_NN ._.
None_NN of_IN these_DT three_CD serums_NNS had_VBD any_DT lytic_JJ power_NN against_IN sheep_JJ RBCs_NNP originally_RB ._.
The_DT three_CD serums_NNS at_IN the_DT time_NN of_IN the_DT experiment_NN differed_VBN in_IN their_PRP$ individual_JJ amboceptoral_JJ activities_NNS ,_, Goat_NNP B_NNP being_VBG the_DT most_RBS potent_JJ ,_, Goat_NNP K_NNP next_JJ and_CC the_DT pony_NN last_JJ ._.
Equal_JJ quantities_NNS of_IN washed_JJ sheep_JJ RBCs_NNP were_VBD sensitized_VBN in_IN equal_JJ parts_NNS of_IN these_DT three_CD heated_VBD serums_NNS ,_, respectively_RB ,_, and_CC after_IN washing_VBG were_VBD put_VBN up_RP with_IN serums_NNS from_IN a_DT normal_JJ horse_NN ,_, sheep_NN and_CC goat_NN as_IN complements_NNS ._.
Nine_JJ series_NN were_VBD thus_RB obtained_VBN for_IN comparison_NN ,_, namely23_CC TABLE_NNP No_NNP ._.
8_CD ._.
Quantities_NNS of_IN complement_NN required_VBN for_IN ``_`` partial_JJ ''_'' lysis_NN ,_, 3o_CD to_TO 40_CD per_IN cent_NN ._.
24_CD Roughly_NNP ,_, the_DT relative_JJ strengths_NNS of_IN these_DT five_CD complements_NNS may_MD be_VB expressed_VBN as_IN under:25_NN that_IN the_DT complement_NN normally_RB present_JJ in_IN a_DT serum_NN is_VBZ able_JJ to_TO give_VB more_JJR lysis_NN with_IN RBCs_NNP sensitized_VBD in_IN a_DT foreign_JJ immune_NN body_NN than_IN with_IN the_DT unsensitized_JJ RBCs_NNP ._.
One_CD would_MD conclude_VB ,_, therefore_RB ,_, that_DT amboceptor_NN is_VBZ deficient_JJ in_IN a_DT normal_JJ serum_NN and_CC that_IN there_EX is_VBZ always_RB sufficient_JJ complement_NN present_NN for_IN any_DT one_CD amboceptor_NN at_IN least_JJS ._.
If_IN another_DT amboceptor_NN be_VB present_JJ there_EX is_VBZ still_RB some_DT complement_NN to_TO combine_VB with_IN it_PRP after_IN the_DT first_JJ has_VBZ been_VBN exhausted_VBN ._.
When_WRB a_DT serum_NN naturally_RB lyses_VBZ RBCs_NNP it_PRP seems_VBZ likely_JJ to_TO lead_VB to_TO fallacies_NNS to_TO compare_VB its_PRP$ complementing_VBG power_NN with_IN that_DT of_IN a_DT serum_NN which_WDT does_VBZ not_RB naturally_RB lyse_VBP those_DT RBCs_NNP ._.
It_PRP does_VBZ not_RB seem_VB justifiable_JJ ,_, therefore_RB ,_, to_TO conclude_VB from_IN the_DT above_NN table_NN that_WDT goat_NN ,_, sheep_NN and_CC horse_NN are_VBP actually_RB so_RB much_JJ poorer_NN in_IN complement_NN for_IN sheep_JJ RBCs_NNP sensitized_VBD in_IN goat_NN K_NNP antisheep_RB serum_VBD as_IN might_MD at_IN first_JJ sight_NN appear_NN ,_, but_CC ,_, all_DT things_NNS considered_VBN ,_, it_PRP is_VBZ certainly_RB prob-_JJ able_JJ ._.
One_CD thing_NN at_IN least_JJS stands_NNS out_RP without_IN doubt_NN ,_, and_CC that_DT is_VBZ ,_, that_IN guinea-pig_JJ serum_NN ,_, which_WDT normally_RB has_VBZ but_CC little_JJ lytic_JJ power_NN against_IN sheep_JJ RBCs_NNP and_CC may_MD on_IN that_DT account_NN be_VB rightly_RB compared_VBN ,_, is_VBZ vastly_RB superior_JJ in_IN complement_NN content_NN to_TO goat_VB ,_, sheep_VB or_CC horse_NN ._.
6_CD ._.
The_DT Complementing_NNP Power_NNP of_IN Homogenous_NNP Serums_NNP ._.
It_PRP appears_VBZ that_IN except_IN in_IN the_DT case_NN of_IN the_DT guinea-pig_JJ the_DT fresh_JJ serum_NN of_IN verte-_JJ brates_NNS can_MD exert_VB little_JJ or_CC no_DT complementing_VBG power_NN when_WRB in_IN contact_NN with_IN RBCs_NNP of_IN the_DT same_JJ species_NNS which_WDT have_VBP been_VBN sensitized_VBN in_IN heterogenous_JJ serums_NNS ._.
In_IN the_DT table_NN given_VBN (_( No_UH ._.
13_CD )_) not_RB all_PDT the_DT serums_NNS employed_VBN were_VBD able_JJ to_TO lyse_VB the_DT RBCs_NNP sensitized_VBN in_IN them_PRP in_IN the_DT fresh_JJ state_NN ,_, through_IN deficiency_NN of_IN either_DT amboceptor_NN or_CC complement_NN ._.
In_IN the_DT case_NN of_IN lysis_NN by_IN guinea-pig_JJ complement_JJ natural_JJ deviation*_NN was_VBD several_JJ times_NNS observed_VBN ,_, i.e._FW ,_, a_DT higher_JJR degree_NN of_IN lysis_NN occurred_VBD in_IN the_DT middle_JJ tubes_NN of_IN the_DT series_NN than_IN at_IN either_DT end_NN ._.
TABLE_NN No_DT ._.
13_CD ._.
Complementing_VBG power_NN of_IN homogenous_JJ serums_NNS ._.
RBCs_NNP sensitized_VBD in_IN heterogenous_JJ serums_NNS and_CC then_RB washed_VBD ._.
Animals_NNS furnishing_VBG the_DT RBCs_NNP and_CC complement_NN ._.
Animals_NNS furnishing_VBG the_DT serum_NN used_VBN for_IN sensitization_NN ._.
Guinea-_JJ pig_NN ._.
Rabbit_NN ._.
Man_NN ._.
Goat_NNP ._.
Sheep_NNP ._.
Horse_NN ._.
Dog_NNP ._.
Hen_NNP ._.
Cat_NNP ._.
Guinea-pig_JJ S-P_NNP S_NNP S_NNP P_NNP S_NNP P_NNP O_NNP 26_CD In_IN this_DT and_CC the_DT following_JJ tables27_NN Arranging_VBG the_DT complements_NNS as_RB far_RB as_IN possible_JJ in_IN order_NN of_IN potency_NN we_PRP get_VBP ,_, roughly:28_VBP RBCs_NNP in_IN the_DT proportions_NNS of_IN IO_NNP and_CC IOO_NNP of_IN serum_NN to_TO I_PRP of_IN RBCs_NNP ._.
The_DT homo-_JJ genous_JJ serums_NNS were_VBD used_VBN as_IN complement_NN ,_, but_CC no_DT lysis_NN occurred_VBD with_IN either_DT IO_NNP to_TO I_PRP or_CC IOO_NNP to_TO I_PRP sensitization_NN ,_, even_RB when_WRB 84_CD per_IN cent_NN ._.
complement_NN was_VBD present_JJ in_IN the_DT tube_NN ,_, except_IN in_IN the_DT case_NN of_IN the_DT guinea-pig_JJ RBCs_NNP ;_: and_CC even_RB with_IN them_PRP only_RB slightly_RB more_JJR lysis_NN was_VBD given_VBN by_IN the_DT IOO_NNP to_TO I_PRP sensitization_NN than_IN by_IN the_DT IO_NNP to_TO I_PRP ._.
It_PRP is_VBZ evident_JJ that_IN the_DT amboceptor_NN had_VBD not_RB been_VBN fixed_VBN ,_, and_CC the_DT conclu-_JJ sion_NN arrived_VBN at_IN is_VBZ that_IN mere_JJ increase_NN of_IN the_DT quantity_NN of_IN a_DT normal_JJ serum_NN ,_, up_RB to_TO practically_RB infinity_NN ,_, does_VBZ not_RB cause_VB foreign_JJ RBCs_NNP ,_, which_WDT are_VBP strongly_RB lysed_VBN by_IN that_DT serum_NN when_WRB unheated_JJ ,_, to_TO fix_VB enough_JJ amboceptor_NN to_TO enable_VB them_PRP to_TO be_VB lysed_VBN by_IN large_JJ doses_NNS of_IN their_PRP$ homogenous_JJ complement.The_NN presence_NN or_CC absence_NN of_IN added_JJ isotonic_JJ NaCl_NNP in_IN the_DT sensitizing_NN fluid_NN has_VBZ no_DT effect_NN on_IN the_DT fixation_NN of_IN amboceptor_NN ._.
That_IN a_DT certain_JJ quantity_NN of_IN amboceptor_NN ,_, and_CC occasionally_RB the_DT greater_JJR portion_NN ,_, can_MD be_VB fixed_VBN in_IN a_DT normal_JJ serum_NN by_IN foreign_JJ RBCs_NNP is_VBZ easily_RB demonstrated_VBN ,_, also_RB that_IN complement_NN can_MD not_RB be_VB withdrawn_VBN from_IN a_DT normal_JJ serum_NN by_IN its_PRP$ homogenous_JJ RBCs_NNP ._.
In_IN one_CD experiment_NN it_PRP was_VBD found_VBN that_IN treatment_NN of_IN rabbit_NN serum_NN by_IN heated_JJ rabbit_NN RBCs_NNP did_VBD not_RB lessen_VB the_DT lytic_JJ power_NN of_IN that_DT rabbit_NN serum_NN against_IN sheep_JJ RBCs_NNP ,_, so_IN no_DT complement_NN had_VBD been_VBN withdrawn_VBN ._.
It_PRP was_VBD also_RB found_VBN that_IN if_IN heated_VBN rabbit_NN RBCs_NNP were_VBD sensitized_VBN in_IN heated_JJ dog_NN serum_NN and_CC then_RB digested_VBD with_IN unheated_JJ rabbit_NN serum_NN ,_, enough_JJ complement_NN was_VBD withdrawn_VBN from_IN the_DT latter_NN to_TO prevent_VB it_PRP giving_VBG any_DT lysis_NN with_IN sheep_JJ RBCs_NNP ._.
7_CD ._.
Deviation_NN of_IN Complement_NNP ._.
For_IN specific_JJ precipitation_NN to_TO occur_VB it_PRP is_VBZ necessary_JJ that_IN the_DT molecules_NNS of_IN precipitinogen_NN should_MD fix_VB a_DT certain_JJ number_NN of_IN molecules_NNS of_IN precipitin_NN ._.
If_IN the_DT precipitinogen_NN is_VBZ in_IN excess_NN in_IN the_DT first_JJ place_NN ,_, the_DT molecules_NNS of_IN precipitin_NN are_VBP so_RB distributed_JJ amongst_VBP them_PRP that_IN no_DT precipitinogen_NN molecule_NN can_MD fix_VB sufficient_JJ preci-_JJ pitin_NN to_TO enable_VB a_DT precipitate_NN to_TO be_VB formed_VBN ._.
If_IN the_DT precipitinogen_NN is_VBZ not_RB in_IN excess_NN to_TO begin_VB with_IN ,_, a_DT precipitate_NN is_VBZ formed_VBN and_CC is_VBZ not_RB re-dissolved_VBN on_IN the_DT addition_NN of_IN more_JJR precipitinogen_NN ._.
For_IN lysis_NN to_TO occur_VB it_PRP is_VBZ necessary_JJ that_IN the_DT RBCs_NNP should_MD fix_VB a_DT certain_JJ number_NN of_IN molecules_NNS of_IN complement_NN ._.
This_DT they_PRP can_MD not_RB do_VB at_IN all_DT until_IN sensitized_VBN ._.
If_IN the_DT sensitizing_NN molecules_NNS are_VBP insufficient_JJ ,_, sufficient_JJ complement_NN can_MD not_RB be_VB fixed_VBN ._.
If_IN the_DT sensitizing_NN molecules_NNS are_VBP sufficient_JJ ,_, enough_JJ complement_NN is_VBZ fixed_VBN for_IN complete_JJ lysis_NN ._.
If_IN the_DT sensitizing_NN molecules_NNS are_VBP in_IN excess_JJ ,_, they_PRP may_MD be_VB attached_VBN nevertheless_RB to_TO the_DT RBCs_NNP ,_, but_CC since_IN the_DT complement_NN is_VBZ in_IN defect_NN ,_, the_DT proportion_NN of_IN the_DT two_CD which_WDT is_VBZ necessary_JJ for_IN the_DT optimum_JJ degree_NN of_IN lysis_NN is_VBZ not_RB appropriate_JJ and_CC ``_`` deviation_NN ''_'' appears_VBZ ._.
It_PRP is_VBZ probable_JJ that_IN the_DT proportion_NN of_IN amboceptor_NN to_TO complement_NN required_VBN for_IN the_DT optimum_JJ degree_NN of_IN lysis_NN varies_NNS with_IN the_DT RBC_NNP and_CC with_IN the_DT sensitizer_NN ,_, and_CC that_IN the_DT range_NN of_IN combination_NN which_WDT results_NNS in_IN the_DT optimum_JJ degree_NN of_IN lysis_NN also_RB varies_VBZ widely_RB ,_, so_IN that_DT in_IN some_DT cases_NNS a_DT slight_JJ excess_NN of_IN sensitizer_NN shows_NNS deviation_NN and_CC in_IN others_NNS almost_RB an_DT infinite_JJ quantity_NN is_VBZ required_VBN to_TO demonstrate_VB it.RBCs_NN probably_RB lose_VB their_PRP$ affinity_NN for_IN sensitizer_NN in_IN proportion_NN to_TO the_DT amount_NN of_IN it_PRP that_WDT has_VBZ been_VBN fixed_VBN ._.
It_PRP is_VBZ quite_RB possible_JJ that_IN in_IN certain_JJ cases_NNS RBCs_NNP may_MD be_VB unable_JJ to_TO fix_VB a_DT much_RB larger_JJR number_NN of_IN sensitizing_VBG molecules_NNS than_IN is_VBZ absolutely_RB required_VBN for_IN the_DT optimum_JJ combination_NN ._.
Deviation_NN of_IN complement_NN can_MD then_RB be_VB demonstrated_VBN with_IN difficulty_NN or_CC not_RB at_IN all_DT ._.
Deviation_NN can_MD only_RB be_VB demonstrated_VBN clearly_RB when_WRB RBCs_NNP can_MD fix_VB sensitizing_VBG molecules_NNS in_IN notable_JJ excess_NN of_IN the_DT actual_JJ requirements_NNS for_IN the_DT optimum_JJ combination_NN ._.
The_DT complement_NN molecules_NNS are_VBP in_IN this_DT case_NN divided_VBD up_RP amongst_IN the_DT attached_JJ sensitizing_NN molecules_NNS ,_, but_CC not_RB necessarily_RB equally_RB amongst_VBZ the_DT RBCs_NNP present_NN ,_, and_CC so_RB many_JJ RBCs_NNP do_VBP not_RB get_VB enough_RB to_TO permit_VB them_PRP to_TO be_VB lysed_VBN ._.
If_IN the_DT excess_NN of_IN sensitizer_NN is_VBZ great_JJ there_EX may_MD be_VB only_RB ``_`` slight_JJ ''_'' lysis_NN or_CC ``_`` trace_NN ''_'' lysis_NN ,_, or_CC conceivably_RB none_NN at_IN all_DT ._.
29_CD Sheep_NNP RBCs_NNP generally_RB have_VBP not_RB been_VBN able_JJ to_TO fix_VB much_RB more_JJR of_IN our_PRP$ Goat_NNP B_NNP antisheep_NN sensitizing_VBG molecules_NNS than_IN they_PRP require_VBP for_IN the_DT optimum_JJ combination_NN ._.
We_PRP found_VBD that_IN 2.6_CD cc_NN ._.
of_IN heated_VBN goat_NN B_NNP serum_NN on_IN one_CD occasion_NN gave_VBD the_DT maximum_JJ degree_NN of_IN sensitization_NN obtainable_JJ with_IN 10_CD cc_NNS ._.
washed_VBN sheep_JJ RBCs_NNP ,_, using_VBG fresh_JJ sheep_JJ serum_NN in_IN excess_NN as_IN complement_NN ._.
When_WRB up_RB to_TO 4.5_CD times_NNS that_IN quantity_NN of_IN sensitizing_VBG serum_NN was_VBD used_VBN ,_, no_DT further_JJ sensitization_NN occurred_VBD ,_, as_IN shown_VBN by_IN an_DT increased_JJ range_NN of_IN lysis_NN with_IN diminishing_VBG quantities_NNS of_IN complement_NN ,_, nor_CC was_VBD any_DT trace_NN of_IN deviation_NN noticed_VBN when_WRB the_DT quantity_NN of_IN complement_NN remained_VBN at_IN the_DT previously_RB found_VBN optimum_NN ._.
Working_VBG with_IN Goat_NNP K_NNP antisheep_JJ serum_NN another_DT method_NN was_VBD tried_VBN ._.
Instead_RB of_IN sensitizing_VBG RBCs_NNP in_IN varying_VBG quantities_NNS of_IN the_DT immune_JJ serum_NN ,_, mixtures_NNS were_VBD made_VBN ,_, each_DT containing_VBG 1_CD cc_NN ._.
of_IN fresh_JJ Goat_NNP K_NNP serum_NN and_CC increasing_VBG quantities_NNS of_IN heated_JJ goat_NN K_NNP serum_NN ,_, and_CC series_NN were_VBD put_VBN up_RP with_IN these_DT mixtures_NNS ._.
The_DT several_JJ mixtures_NNS contained_VBD diminishing_VBG amounts_NNS of_IN complement_NN and_CC increasing_VBG amounts_NNS of_IN ambocep-_JJ tor_NN ._.
Even_RB when_WRB the_DT relation_NN of_IN amboceptor_NN to_TO complement_NN was_VBD as_IN 8_CD to_TO 1_CD no_DT deviation_NN occurred_VBD and_CC the_DT degree_NN of_IN lysis_NN resulting_VBG appeared_VBD to_TO vary_VB inversely_RB as_IN the_DT quantity_NN of_IN complement_JJ present_NN ._.
The_DT matter_NN may_MD be_VB rendered_VBN clearer_JJR if_IN put_VBN into_IN tabular_JJ form_NN ._.
Let_VB us_PRP assume_VB that_IN RBCs_NNP sensitized_VBD with30_JJ Series_NNP A_NNP had_VBD evidently_RB absorbed_VBN rather_RB more_RBR amboceptor_NN than_IN was_VBD compatible_JJ with_IN complete_JJ lysis_NN by_IN the_DT minimum_JJ active_JJ dose_NN of_IN complement_NN as_IN indicated_VBN by_IN B_NNP &_CC C._NNP The_DT concentration_NN of_IN amboceptor_NN in_IN the_DT serum_NN was_VBD somewhat_RB reduced_VBN by_IN the_DT removal_NN of_IN the_DT amount_NN absorbed_VBN by_IN A_NNP ,_, considerably_RB reduced_VBN by_IN B_NNP ,_, yet_RB enough_RB remained_VBN to_TO sensitize_VB C_NNP as_RB fully_RB as_IN B_NNP ._.
Some_DT information_NN as_IN to_TO the_DT influence_NN of_IN the_DT available_JJ quantity_NN of_IN amboceptor_NN and_CC of_IN its_PRP$ concentration_NN in_IN the_DT sensitizing_NN fluid_NN was_VBD gained_VBN in_IN further_JJ experiments_NNS ._.
(_( a_DT )_) 1.2_CD cc_NN ._.
washed_VBN sheep_JJ RBCs_NNP were_VBD sensitized_VBN in_IN 1.8_CD cc_NN ._.
heated_VBN goat_NN B_NNP serum_NN ,_, and_CC another_DT (_( b_NN )_) 1.2_CD cc_NN ._.
RBCs_NNP in_IN 1.8_CD cc_NN ._.
serum_NN +_VBZ 198.2_CD cc_NN ._.
of_IN 0.85_CD per_IN cent_NN ._.
NaCL_NNP ._.
The_DT actual_JJ quantity_NN of_IN amboceptor_NN in_IN (_( b_NN )_) was_VBD the_DT same_JJ as_IN in_IN (_( a_DT )_) ,_, but_CC its_PRP$ con-_JJ centration_NN was_VBD only_RB 1/100_CD ._.
In_IN the_DT two_CD series_NN put_VBD up_RP after_IN sensitization_NN precisely_RB similar_JJ degrees_NNS of_IN lysis_NN were_VBD given_VBN by_IN guinea-pig_JJ complement_NN (_( 0.017_CD =_NNP C_NNP lysis_NN )_) ,_, so_RB in_IN spite_NN of_IN the_DT great_JJ diminution_NN of_IN concentration_NN the_DT RBCs_NNP in_IN (_( b_NN )_) had_VBD in_IN one_CD hour_NN picked_VBD up_RP sufficient_JJ amboceptor_NN for_IN full_JJ sensitization_NN ._.
As_RB long_RB as_IN amboceptor_NN is_VBZ in_IN excess_NN of_IN the_DT absorptive_JJ limits_NNS of_IN RBCs_NNP it_PRP does_VBZ not_RB appear_VB to_TO matter_VB whether_IN its_PRP$ concentration_NN in_IN the_DT fluid_NN is_VBZ greately_RB reduced_VBN or_CC not_RB ._.
It_PRP is_VBZ possible_JJ that_IN with_IN a_DT lowered_JJ concentration_NN more_JJR time_NN would_MD be_VB taken_VBN to_TO reach_VB the_DT limit_NN of_IN absorption_NN ,_, but_CC on_IN this_DT point_NN we_PRP have_VBP made_VBN no_DT observations_NNS ._.
Other_JJ facts_NNS to_TO be_VB related_VBN presently_RB make_VBP it_PRP seem_RBR probable_JJ that_IN ,_, if_IN the_DT concen_NN tration_NN of_IN amboceptor_NN in_IN an_DT experimental_JJ fluid_NN can_MD be_VB raised_VBN much_RB above_IN that_DT which_WDT may_MD be_VB considered_VBN possible_JJ in_IN the_DT serum_NN of_IN a_DT living_NN animal_NN ,_, the_DT absorptive_JJ power_NN of_IN RBCs_NNP rises_NNS in_IN proportion_NN ._.
There_EX seems_VBZ to_TO be_VB a_DT certain_JJ degree_NN of_IN concentra_JJ tion_NN of_IN amboceptor_NN below_IN which_WDT RBCs_NNP can_MD not_RB fix_VB enough_RB to_TO enable_VB deviation_NN of_IN complement_NN to_TO be_VB demonstrated_VBN ,_, although_IN there_EX may_MD be_VB in_IN actual_JJ quantity_NN sufficient_NN to_TO sensitize_VB many_JJ times_NNS the_DT number_NN of_IN RBCs_NNP to_TO their_PRP$ apparent_JJ limit_NN ._.
Deviation_NN is_VBZ more_RBR easy_JJ to_TO demonstrate_VB when_WRB the_DT immune_NN serum_NN itself_PRP is_VBZ present_JJ than_IN when_WRB RBCs_NNP are_VBP sensitized_VBN and_CC then_RB washed_VBD ;_: and_CC it_PRP is_VBZ often_RB clearly_RB marked_VBN during_IN the_DT first_JJ 20_CD minutes_NNS of_IN incubation_NN in_IN an_DT experiment_NN in_IN which_WDT 1_CD 1/2_CD hours_NNS will_MD render_VB the_DT lysis_NN complete_NN ._.
Deviation_NN could_MD not_RB be_VB demonstrated_VBN by_IN sensitization_NN of_IN sheep_JJ RBCs_NNP in_IN our_PRP$ pony-antisheep-serum_NN ,_, washing_VBG and_CC adding_VBG complement_NN ,_, but_CC was_VBD well_RB shown_VBN in_IN one_CD time-experiment_NN ,_, performed_VBN with_IN another_DT object_NN ,_, in_IN which_WDT the_DT serum_NN itself_PRP was_VBD present_JJ in_IN the_DT hæmolytic_JJ system_NN (_( vide_JJ Chart_NNP 4_CD )_) ._.
When_WRB ,_, however_RB ,_, the_DT amboceptor_NN was_VBD presented_VBN to_TO the_DT sheep_JJ RBCs_NNP in_IN the_DT form_NN of_IN a_DT solution_NN of_IN the_DT dried_JJ globulins_NNS of_IN the_DT antisheep_JJ serum_NN ,_, obtained_VBN by_IN salting_VBG out_RP ,_, dialysing_VBG and_CC drying_VBG in_IN vacuo_NN over_IN H2SO4_NNP ,_, complete_JJ deviation_NN was_VBD readily_RB shown_VBN ._.
It_PRP seems_VBZ as_IN if_IN the_DT amboceptor_NN were_VBD more_RBR powerful_JJ in_IN the_DT absence_NN of_IN the_DT albuminous_JJ and_CC lipochrome_JJ elements_NNS of_IN the_DT serum_NN than_IN in_IN the_DT whole_JJ serum_NN ,_, but_CC this_DT we_PRP have_VBP not_RB proved_VBN with_IN exactitude_NN ._.
It_PRP is_VBZ easy_JJ by_IN this_DT means_VBZ to_TO obtain_VB a_DT solution_NN containing_VBG amboceptor_NN in_IN 4_CD times_NNS the_DT concentration_NN in_IN which_WDT it_PRP is_VBZ found_VBN in_IN the_DT original_JJ serum_NN ._.
The_DT oretically_RB a_DT much_RB higher_JJR concentration_NN is_VBZ possible_JJ ,_, but_CC in_IN practice_NN it_PRP is_VBZ found_VBN difficult_JJ to_TO induce_VB the_DT dried_JJ globulins_NNS to_TO dissolve_VB in_IN greater_JJR concentration_NN than_IN 4/1_CD in_IN 0.85_CD per_IN cent_NN ._.
salt_JJ solution_NN ._.
Even_RB then_RB the_DT solution_NN is_VBZ turbid_JJ and_CC contains_VBZ much_RB suspended_VBN matter_NN ._.
A_DT nearly_RB clear_JJ solution_NN can_MD be_VB obtained_VBN by_IN filtration_NN through_IN paper_NN ,_, or_CC centrifugation_NN ;_: and_CC the_DT removal_NN of_IN the_DT undissolved_JJ portion_NN does_VBZ not_RB seem_VB to_TO reduce_VB the_DT amboceptoral_JJ potency_NN of_IN the_DT fluid_NN appreciably_RB ,_, so_IN it_PRP may_MD be_VB presumed_VBN that_IN the_DT amboceptor_NN molecules_NNS are_VBP more_RBR soluble_JJ than_IN the_DT globulins_NNS with_IN which_WDT they_PRP are_VBP associated_VBN ._.
A_DT similar_JJ concentration_NN of_IN amboceptors_NNS could_MD be_VB obtained_VBN by_IN drying_VBG the_DT whole_JJ serum_NN and_CC re-dissolving_NN it_PRP in_IN one-fourth_NN of_IN its_PRP$ original_JJ volume_NN of_IN distilled_JJ water_NN ,_, or_CC by_IN evaporation_NN ,_, but_CC all_PDT the_DT other_JJ elements_NNS ,_, including_VBG the_DT salts_NNS ,_, would_MD be_VB concen-_JJ trated_JJ likewise_NN ,_, and_CC lysis_NN would_MD be_VB interfered_VBN with_IN thereby_NN ._.
To_TO face_VB page_NN 30_CD CHART_NNP No_NNP ._.
4_CD To_TO illustrate_VB the_DT deviation_NN of_IN complement_NN occuring_VBG during_IN the_DT early_JJ period_NN of_IN incubation_NN which_WDT in_IN course_NN of_IN time_NN becomes_NNS masked_VBD ._.
In_IN 7_CD minutes_NNS 0.075_CD amboceptor_NN permits_NNS complete_JJ lysis_NN ,_, while_IN 0.2_CD is_VBZ partial_JJ ._.
0.2_CD amboceptor_NN is_VBZ not_RB complete_JJ till_NN 19_CD minutes_NNS ._.
The_DT quantity_NN of_IN complement_NN is_VBZ fixed_VBN throughout_IN ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 74918208.tif_CD ]_JJ Time_NNP of_IN incubation_NN in_IN minutes_NNS ._.
S.O/1911_NNP Reg_NNP :_: No_DT ._.
1261_CD Copies31_NNP 8_CD ._.
The_DT Latent_NNP Antilytic_NNP Property_NNP of_IN Normal_NNP Serum_NNP ._.
Sachs_NNP (_( Ehrlich_NNP 's_POS Studies_NNPS on_IN Immunity_NNP ,_, p._RB 603_CD )_) describes_VB how_WRB a_DT heated_VBN normal_JJ serum_NN ,_, which_WDT has_VBZ been_VBN extracted_VBN with_IN certain_JJ RBCs_NNP ,_, has_VBZ an_DT antilytic_JJ effect_NN on_IN the_DT lysis_NN of_IN RBCs_NNP of_IN the_DT same_JJ species_NNS by_IN a_DT heated_VBN immune_NN serum_NN and_CC complement_NN ._.
One_CD of_IN the_DT experiments_NNS performed_VBN by_IN Sachs_NNP was_VBD as_IN follows:32_NN In_IN (_( 7_CD )_) the_DT exact_JJ conditions_NNS of_IN sachs_NN 's_POS experiment_NN were_VBD imitated_VBN and_CC his_PRP$ find-_JJ ings_NNS were_VBD fully_RB confirmed_VBN ._.
Sachs_NNP explains_VBZ his_PRP$ experiment_NN by_IN assuming_VBG that_IN the_DT normal_JJ amboceptors_NNS circulating_VBG in_IN the_DT blood_NN have_VBP a_DT higher_JJR degree_NN of_IN affinity_NN for_IN complement_NN than_IN artificial_JJ amboceptors_NNS ,_, and_CC that_IN the_DT union_NN of_IN normal_JJ amboceptor_NN molecule_NN and_CC complement_NN molecule_NN can_MD occur_VB in_IN the_DT test_NN tube_NN without_IN previous_JJ union_NN of_IN the_DT amboceptor_NN with_IN a_DT RBC_NNP ._.
In_IN his_PRP$ experiment_NN A_DT heated_VBN normal-rabbit-serum_NN containing_VBG various_JJ ambocep-_JJ tors_NNS is_VBZ incubated_VBN with_IN fresh_JJ guinea-pig_JJ serum_NN ._.
Then_RB heated_VBN rabbit-antisheep-serum_NN and_CC sheep_JJ RBCs_NNP are_VBP added_VBN ._.
The_DT sheep_JJ RBCs_NNP attach_NN both_VBD the_DT normal_JJ amboceptor_NN of_IN the_DT normal-rabbit-serum_JJ and_CC the_DT artificial_JJ amboceptor_NN of_IN the_DT rabbit-antisheep-_JJ serum_NN ._.
Lysis_NN is_VBZ effected_VBN by_IN union_NN of_IN the_DT complement_NN with_IN the_DT attached_VBN normal_JJ amboceptor_NN ,_, for_IN which_WDT it_PRP has_VBZ a_DT greater_JJR affinity_NN than_IN for_IN either_CC the_DT attached_JJ artificial_JJ amboceptor_NN or_CC the_DT free_JJ normal_JJ amboceptors_NNS of_IN other_JJ kinds_NNS ._.
In_IN his_PRP$ experiment_NN B_NNP the_DT same_JJ procedure_NN is_VBZ followed_VBN but_CC the_DT normal-rabbit-serum_NN is_VBZ first_RB digested_VBN with_IN washed_JJ sheep_NN RBCs_NNP which_WDT extract_VBP the_DT normal_JJ sheep_JJ amboceptor_NN from_IN it_PRP ._.
When_WRB the_DT antisheep_NN serum_NN and_CC sheep_JJ RBCs_NNP are_VBP finally_RB added_VBN the_DT RBCs_NNP find_VBP no_DT normal_JJ amboceptor_NN to_TO fix_VB ,_, but_CC only_RB artificial_JJ amboceptor_NN ._.
The_DT guinea-pig_JJ complement_NN is_VBZ supposed_VBN to_TO have_VB a_DT higher_JJR degree_NN of_IN affinity_NN for_IN the_DT free_JJ normal_JJ amboceptors_NNS of_IN other_JJ kinds_NNS in_IN the_DT rabbit_NN serum_NN than_IN for_IN the_DT artificial_JJ amboceptor_NN attached_VBD to_TO the_DT RBCs_NNP ._.
The_DT complement_NN molecules_VBZ consequently_RB remain_VBP united_JJ to_TO these_DT free_JJ amboceptors_NNS and_CC do_VBP not_RB combine_VB with_IN the_DT artificially_RB sensitized_JJ RBCs_NNP ._.
Hence_NNP there_EX is_VBZ no_DT lysis_NN ._.
The_DT free_JJ normal_JJ amboceptors_NNS ,_, therefore_RB ,_, are_VBP supposed_VBN to_TO act_VB as_IN anticomplements_NNS and_CC to_TO deviate_VB the_DT complement_NN ._.
On_IN this_DT hypothesis_NN in_IN our_PRP$ experiment_NN (_( 3_CD )_) the_DT absence_NN of_IN prevention_NN of_IN lysis_NN can_MD only_RB be_VB explained_VBN by_IN assuming_VBG that_IN goat_NN complement_NN has_VBZ a_DT greater_JJR affinity_NN for_IN goat_NN antisheep_NN amboceptor_NN in_IN combination_NN with_IN sheep_JJ RBCs_NNP than_IN it_PRP has_VBZ for_IN free_JJ normal_JJ amboceptors_NNS ,_, whereas_IN the_DT converse_NN is_VBZ the_DT case_NN with_IN guinea-pig_JJ complement_NN ._.
This_DT is_VBZ supported_VBN by_IN our_PRP$ experiment_NN (_( 4_CD )_) ._.
Sachs_NNP 's_POS interpretation_NN involves_VBZ the_DT view_NN that_IN there_EX can_MD be_VB union_NN between_IN amboceptor_NN and_CC complement_NN molecules_NNS without_IN union_NN of_IN the_DT former_JJ with_IN RBCs_NNP ,_, which_WDT is_VBZ by_IN no_DT means_NNS generally_RB accepted_VBN (_( vide_IN ``_`` Deviation_NNP ,_, ''_'' p._VBZ 28_CD )_) ._.
It_PRP is_VBZ recognised_VBN that_IN the_DT reactions_NNS (_( 1_CD )_) RBC_NNP +_NNP Amboceptor=_NNP (_( RBC_NNP +_NNP Amboceptor_NNP )_) and_CC (_( 2_CD )_) (_( RBC_NNP +_NNP Amboceptor_NNP )_) +_FW complement_NN =_JJ lysis_NN take_VB an_DT appreciable_JJ time_NN ,_, the_DT length_NN of_IN which_WDT is_VBZ related_VBN to_TO the_DT quantities_NNS present_JJ and_CC to_TO the_DT temperature_NN If_IN amboceptor_NN and_CC complement_NN were_VBD already_RB united_VBN in_IN the_DT fluid_NN it_PRP would_MD seem_VB probable_JJ that_IN the_DT reaction_NN (_( C_NNP +_NNP A_NNP )_) +_NN RBC_NNP =_NNP lysis_NN would_MD be_VB more_RBR rapid_JJ than_IN the_DT reaction_NN RBC_NNP +_VBZ A_NNP +_NNP C_NNP =_NNP lysis_NN To_TO put_VB this_DT to_TO the_DT test_NN we_PRP took_VBD heated_VBN pony-antisheep-serum_NN for_IN amboceptor_NN ,_, fresh_JJ guinea-pig_NN serum_NN for_IN complement_NN ,_, and_CC washed_VBD sheep_JJ RBCs_NNP ._.
Two_CD series_NN ,_, A_NNP and_CC B_NNP ,_, were_VBD put_VBN up_RP ,_, and_CC the_DT degree_NN of_IN lysis_NN in_IN the_DT tubes_NNS noted_VBD every_DT three_CD minutes_NNS ._.
In_IN A_NNP ,_, amboceptor_NN and_CC complement_NN were_VBD incubated_VBN together_RB for_IN an_DT hour_NN before_IN adding_VBG the_DT RBCs_NNP ;_: in_IN B_NNP ,_, amboceptor_NN ,_, complement_NN and_CC RBCs_NNP were_VBD incubated_VBN separately_RB ._.
The_DT racks_NNS ,_, pipettes_NNS and_CC tubes_NNS used_VBN were_VBD all_DT similarly_RB incubated_VBN ,_, and_CC the_DT final_JJ mixtures_NNS were_VBD made_VBN with_IN the_DT utmost_JJ rapidity_NN ._.
No_DT acceleration_NN of_IN lysis_NN was_VBD observed_VBN in_IN series_NN A_NNP in_IN which_WDT amboceptor_NN and_CC complement_NN had_VBD been_VBN given_VBN an_DT opportunity_NN of_IN uniting_VBG before_IN the_DT addition_NN of_IN the_DT RBCs_NNP ;_: so_IN it_PRP must_MD be_VB concluded_VBN either_CC that_IN amboceptor_NN and_CC complement_NN do_VBP not_RB unite_VB in_IN the_DT absence_NN of_IN RBCs_NNP or_CC that_IN ,_, if_IN they_PRP do_VBP unite_RB ,_, the_DT combination_NN thus_RB formed_VBD does_VBZ not_RB produce_VB lysis_NN with_IN greater_JJR velocity_NN than_IN when_WRB amboceptor_NN and_CC com-_JJ plement_NN meet_VB the_DT RBCs_NNP without_IN previous_JJ combination_NN ._.
To_TO face_VB page_NN 33_CD CHART_NNP NO.7_NNP Showing_VBG the_DT effect_NN of_IN incubation_NN on_IN the_DT degree_NN of_IN lysis_NN obtained_VBN when_WRB the_DT complement_NN is_VBZ in_IN high_JJ dilution_NN ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 74918217.tif_CD ]_JJ S.O./1911_NNP Reg_NNP :_: No_DT ._.
1264_CD copies_NNS To_TO face_VB page_NN 33_CD CHART_NNP NO_NNP ._.
6_CD Showing_VBG the_DT effect_NN on_IN lysis_NN of_IN dilution_NN of_IN four_CD different_JJ concentrations_NNS of_IN complement_JJ Dilution_NNP of_IN complement_NN [_NNP NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 74918220.tif_CD ]_JJ Percentage_NNP concentration_NN of_IN complement_JJ S._NNP O./1911_NNP Reg_NNP :_: No_DT ._.
1283_CD copies_NNS To_TO face_VB page_NN 33_CD CHART_NNP NO_NNP ._.
5_CD Showing_VBG the_DT effect_NN on_IN lysis_NN of_IN the_DT dilution_NN of_IN the_DT complement_NN ._.
the_DT actual_JJ quantity_NN remaining_VBG constant_JJ ._.
Time_NNP of_IN incubation_NN 1½_CD hours_NNS [_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 74918223.tif_CD ]_JJ S.O_NNP ._.
1911_CD Reg_NNP :_: No_DT ._.
1262_CD copies_NNS 33_CD 9_CD ._.
Various_JJ Factors_NNS which_WDT influence_VBP Specific_JJ Lysis_NNP ._.
For_IN practical_JJ purposes_NNS it_PRP is_VBZ desirable_JJ to_TO be_VB aware_JJ of_IN the_DT effect_NN of_IN dilution_NN of_IN complement_NN and_CC of_IN the_DT lessening_NN of_IN lysis_NN that_WDT may_MD be_VB expected_VBN on_IN this_DT account_NN ._.
Series_NNS were_VBD therefore_RB put_VBN up_RP with_IN each_DT tube_NN containing_VBG equal_JJ quantities_NNS of_IN previously_RB sensitized_VBN RBCs_NNP and_CC of_IN complement_NN ,_, but_CC increasing_VBG volumes_NNS of_IN salt_JJ solution_NN ._.
Chart_NNP No_NNP ._.
5_CD shows_NNS graphically_RB the_DT result_NN of_IN the_DT experiments_NNS ._.
When_WRB the_DT con-_JJ centration_NN of_IN complement_NN was_VBD above_IN II_NNP percent_NN ._.
complete_JJ lysis_NN occurred_VBD ;_: when_WRB the_DT concentration_NN was_VBD 8.30_CD per_IN cent_NN ._.
there_EX was_VBD 75_CD per_IN cent_NN ._.
of_IN lysis_NN ,_, when_WRB 5.75_CD per_IN cent_NN ._.
there_EX was_VBD 50_CD per_IN cent_NN ;_: of_IN lysis_NN ;_: and_CC when_WRB only_RB 3.9_CD per_IN cent_NN ._.
there_EX was_VBD practically_RB no_DT lysis_NN within_IN one_CD and_CC a_DT half_NN hours_NNS ,_, the_DT time_NN limit_NN of_IN the_DT experiment_NN ._.
Within_IN limits_NNS it_PRP may_MD be_VB seated_VBN that_IN the_DT degree_NN of_IN lysis_NN in_IN a_DT given_VBN time_NN ,_, the_DT quantity_NN of_IN complement_NN remaining_VBG constant_JJ ,_, is_VBZ inversely_JJ proportional_JJ ,_, to_TO the_DT concentration_NN of_IN that_DT comple-_JJ ment_NN in_IN the_DT mixture_NN ._.
Chart_NNP No_NNP ._.
6_CD shows_NNS that_IN ,_, under_IN the_DT particular_JJ conditions_NNS of_IN an_DT experiment_NN ,_, complete_JJ lysis_NN occurred_VBD with_IN dilutions_NNS of_IN complement_NN below_IN 10_CD per_IN cent_NN ._.
and_CC ``_`` trace_NN ''_'' lysis_NN with_IN a_DT dilution_NN of_IN 30_CD per_IN cent_NN ._.
Again_NNP for_IN practical_JJ purposes_NNS it_PRP is_VBZ desirable_JJ to_TO be_VB certain_JJ whether_IN different_JJ periods_NNS of_IN incubation_NN within_IN the_DT ordinary_JJ experimental_JJ limits_NNS have_VBP an_DT influence_NN to_TO ,_, be_VB reckoned_VBN with_IN in_IN dealing_VBG with_IN small_JJ quantities_NNS of_IN complement_NN ,_, i.e._FW ,_, whether_IN a_DT quantity_NN of_IN complement_NN which_WDT does_VBZ not_RB give_VB an_DT appreciable_JJ deree_NN of_IN lysis_NN ,_, say_VBP ,_, in_IN 3034_CD goat-antisheep-serum_NN ,_, with_IN fresh_JJ sheep_JJ serum_NN as_IN complement_NN ,_, and_CC different_JJ propor-_JJ tions_NNS of_IN sheep_JJ serum_NN (_( 55°C_CD ._. )_)
as_IN the_DT inhibiting_NN ,_, agent_NN ._.
It_PRP will_MD be_VB seen_VBN that_IN in_IN the_DT presence_NN of_IN 72_CD per_IN cent_NN ._.
sheep_JJ serum_NN (_( 55°_CD )_) twice_RB as_RB much_JJ complement_NN was_VBD required_VBN for_IN complete_JJ lysis_NN as_IN when_WRB the_DT serum_NN was_VBD re-_JJ placed_VBN by_IN 0.85_CD per_IN cent_NN ._.
salt_NN solution_NN ,_, 54_CD per_IN cent_NN ,_, inhibited_VBN in_IN a_DT lesser_JJR degree_NN ,_, 36_CD per_IN cent_NN ,_, scarcely_RB at_IN all_DT ,_, while_IN 18_CD per_IN cent_NN ._.
on_IN the_DT other_JJ hand_NN had_VBD an_DT auxilytic_JJ influence_NN ._.
A_DT similar_JJ result_NN is_VBZ produced_VBN by_IN the_DT heated_JJ serum_NN of_IN an_DT animal_JJ homogenous_JJ with_IN the_DT erythrocytes_NNS used_VBN ,_, when_WRB a_DT heterogenous_JJ serum_NN is_VBZ the_DT lytic_JJ agent_NN ._.
For_IN example_NN ,_, when_WRB fresh_JJ man_NN serum_NN was_VBD used_VBN as_IN the_DT lytic_JJ agent_NN against_IN sheep_JJ erythrocytes_NNS ,_, a_DT concentration_NN of_IN 0.11_CD gave_VBD complete_JJ lysis_NN ._.
When_WRB 60_CD per_IN cent_NN ,_, heated_VBN sheep_JJ serum_NN was_VBD present_JJ three_CD times_NNS that_IN quantity_NN of_IN man_NN serumgave_VBP only_RB a_DT trace_NN of_IN lysis_NN ._.
Sixty_NNP per_IN cent_NN ._.
fresh_JJ unheated_JJ sheep_NN serum_NN also_RB inhibited_VBD lysis_NN considerably_RB ,_, but_CC less_JJR than_IN the_DT heated_JJ serum_NN ._.
When_WRB sheep_NN serum_NN which_WDT had_VBD been_VBN decomplemented_VBN by_IN the_DT action_NN of_IN heated_JJ rabbit_NN erythrocytes_NNS was_VBD used_VBN as_IN the_DT inhibiting_NN agent_NN ,_, it_PRP wasfound_VBD that_IN heating_VBG from_IN 30To_CD face_NN page_NN 34_CD CHART_NNP NO_NNP ._.
8_CD Showing_VBG that_IN increasing_VBG quantities_NNS of_IN complement_NN are_VBP required_VBN to_TO produce_VB lysis_NN as_IN the_DT percentage_NN of_IN heated_JJ serum_NN is_VBZ increased_VBN S.O/1911_NNP Reg_NNP :_: No_NN ,_, 1265_CD copies_NNS To_TO face_VB page_NN 34_CD CHART_NNP No_NNP ._.
9_CD Shows_VBZ that_IN 0.05_CD concentration_NN of_IN complement_NN effected_VBD complete_JJ lysis_NN when_WRB 0.85_CD %_NN NaCI_NNP ._.
was_VBD the_DT diluent_NN ._.
When_WRB either_DT 40_CD %_NN or_CC 70_CD %_NN of_IN sheep_NN serum_NN which_WDT had_VBD been_VBN heated_VBN to_TO 55°_CD C._NNP for_IN ½_NNP hour_NN was_VBD present_JJ complete_JJ lysis_NN was_VBD not_RB effected_VBN with_IN the_DT highest_JJS concentration_NN of_IN complement_NN used_VBN ;_: the_DT points_NNS are_VBP outside_IN the_DT limits_NNS of_IN the_DT chart_NN ._.
when_WRB 40_CD %_NN sheep_NN serum_NN which_WDT had_VBD been_VBN heated_VBN to_TO 55°_CD C._NNP for_IN 24_CD hours_NNS was_VBD present_JJ complete_JJ lysis_NN was_VBD effected_VBN by_IN 0.1_CD concentration_NN of_IN complement_NN ;_: 70_CD %_NN serum_NN increased_VBD this_DT to_TO 0.12_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 74918235.tif_CD ]_JJ Concentration_NNP of_IN complement_NN in_IN tubes_NNS ._.
S_NNP O./1911_NNP Reg_NNP :_: No_DT ._.
1266_CD copies_NNS 35_CD Reformatsky_NNP and_CC Levi_NNP (_( quoted_VBN p._RB 345_CD of_IN Mellor_NNP 's_POS Chemical_NNP Statics_NNPS )_) have_VBP shown_VBN that_IN the_DT velocity_NN of_IN a_DT chemical_JJ reaction_NN is_VBZ not_RB lessened_VBN when_WRB the_DT viscosity_NN is_VBZ increased_VBN by_IN gelatine_NN ,_, agar_NN or_CC silicic_JJ acid_NN ._.
Still_RB ,_, whatever_VBD the_DT cause_NN ,_, increase_NN of_IN viscosity_NN in_IN this_DT case_NN was_VBD accompanied_VBN by_IN less_JJR lysis_NN ._.
Small_JJ quantities_NNS of_IN both_DT egg-albumin_JJ and_CC gelatine_NN in_IN the_DT mixture_NN were_VBD accompanied_VBN by_IN a_DT higher_JJR degree_NN of_IN lysis_NN than_IN when_WRB salt_JJ alone_RB was_VBD present_JJ ._.
TABLE_NN No_DT ._.
16_CD ._.
No_DT ._.
Viscous_JJ medium_NN ._.
Percentage_NN in_IN mixture_NN ._.
Concentration_NN of_IN complement_NN ._.
Lysis_NN ._.
1_CD Heated_JJ sheep_JJ serum_NN 65.0_CD per_IN cent_NN ._.
0.04_CD Complete_NNP ._.
2_CD Dextrin_NNP 5.0_CD ``_`` 0.06_CD ``_`` 3_CD Gum_NNP arabic_VBD 3.2_CD ``_`` 0.088_CD ``_`` 4_CD 0.85_CD per_IN cent_NN ._.
NaCl_NNP control_NN 0.13_CD ``_`` 5_CD Gum_NNP arabic_JJ 5.0_CD per_IN cent_NN ._.
0.22_CD Not_RB complete_JJ ._.
6_CD Do_VBP 6.4_CD ``_`` 0.22_CD ``_`` 7_CD Dextrin_NNP 13.0_CD ``_`` 0.22_CD ``_`` 8_CD Do_NNP ._.
23.0_CD ``_`` 0.22_CD Partial_NNP ._.
Viscosities_NNS of_IN 2_CD &_CC 3_CD viocosity_NN 1_CD ``_`` 5_CD &_CC 7_CD =_NN ``_`` 1_CD ``_`` 6_CD &_CC 8_CD >_NN ``_`` 1_CD Table_JJ No_NNP ._.
16_CD shows_NNS ,_, like_IN Table_NNP No_NNP ._.
15_CD ,_, that_IN the_DT higher_JJR concentrations_NNS of_IN viscous_JJ substances_NNS such_JJ as_IN dextrin_NN and_CC gum_NN arabic_JJ tend_VBP to_TO interfere_VB with_IN lysis_NN ,_, whereas_RB low_JJ concentrations_NNS such_JJ as_IN 5_CD per_IN cent_NN ._.
and_CC 3.2_CD per_IN cent_NN ._.
appear_VB to_TO favour_VB lysis_NN even_RB more_RBR than_IN simple_JJ admixture_NN of_IN 0.85_CD per_IN cent_NN ._.
salt_NN ._.
On_IN this_DT occasion_NN an_DT increase_NN of_IN lysis_NN was_VBD found_VBN in_IN the_DT presence_NN of_IN 65_CD per_IN cent_NN ._.
heated_VBN sheep_JJ serum_NN ._.
This_DT can_MD not_RB have_VB been_VBN due_JJ to_TO added_JJ amboceptor_NN ,_, as_IN normal_JJ sheep_JJ serum_NN contains_VBZ no_DT isolysin_NN for_IN sheep_JJ cells_NNS :_: nor_CC was_VBD it_PRP due_JJ to_TO insufficient_JJ heating_NN ,_, for_IN controls_NNS showed_VBD that_IN it_PRP contained_VBD no_DT complement_NN ._.
No_DT explanation_NN will_MD be_VB offered_VBN at_IN this_DT moment_NN ._.
If_IN the_DT inhibition_NN by_IN heated_JJ serum_NN were_VBD ,_, as_IN a_DT rule_NN ,_, clue_NN to_TO complementoids_VB blocking_VBG the_DT union_NN of_IN complement_NN with_IN amboceptor_NN ,_, one_CD would_MD expect_VB the_DT effect_NN to_TO be_VB the_DT more_RBR marked_VBD the_DT better_JJR opportunity_NN the_DT complementoids_NNS have_VBP ,_, i.e._FW ,_, if_IN additional_JJ heated_VBD serum_NN containing_VBG complementoids_NNS were_VBD incubated_VBN with_IN sensitized_JJ RBCs_NNP before_IN adding_VBG complement_NN ,_, one_CD would_MD expect_VB more_JJR inhibition_NN of_IN lysis_NN than_IN if_IN the_DT complement_NN were_VBD added_VBN immediately_RB ._.
This_DT however_RB does_VBZ not_RB prove_VB to_TO be_VB the_DT case_NN ,_, so_RB if_IN the_DT inhibition_NN of_IN heated_JJ serum_NN is_VBZ clue_JJ to_TO complementoids_NNS they_PRP have_VBP such_PDT an_DT affinity_NN for_IN the_DT amboceptor_NN that_IN they_PRP can_MD block_VB it_PRP quickly_RB in_IN presence_NN of_IN complement_NN ._.
Another_DT explanation_NN may_MD be_VB that_IN any_DT possible_JJ blocking_NN of_IN the_DT complement_NN ophile_IN group_NN of_IN the_DT amboceptor_NN of_IN sensitized_JJ cells_NNS that_WDT can_MD occur_VB has_VBZ already_RB taken_VBN place_NN in_IN the_DT process_NN of_IN sensitization_NN ,_, so_IN that_IN the_DT subsequent_JJ exposure_NN to_TO heated_VBN serum_NN after_IN washing_VBG the_DT sensitized_VBN RBCs_NNP has_VBZ no_DT effect_NN ._.
When_WRB 1.5_CD times_NNS the_DT full_JJ dose_NN of_IN complement_NN for_IN a_DT particular_JJ degree_NN of_IN sensitization_NN was_VBD present_JJ 25_CD per_IN cent.36_NN The_DT inhibitory_JJ effect_NN of_IN the_DT heated_JJ serum_NN can_MD not_RB be_VB due_JJ to_TO the_DT deviating_VBG action_NN of_IN a_DT precipitum_NN ._.
Precipitin_NN in_IN the_DT mixtures_NNS used_VBN in_IN our_PRP$ experiments_NNS would_MD be_VB found_VBN in_IN the_DT heated_JJ anti-sheep_JJ serum_NN ,_, and_CC ,_, even_RB if_IN this_DT clung_NN to_TO the_DT sheep_JJ RBCs_NNP sensitized_VBD in_IN it_PRP after_IN washing_VBG ,_, such_PDT a_DT minute_NN amount_NN would_MD be_VB conveyed_VBN into_IN the_DT mixture_NN that_IN its_PRP$ effect_NN would_MD be_VB negligible_JJ ._.
Precipitinogen_NN in_IN large_JJ quantity_NN would_MD be_VB supplied_VBN by_IN the_DT heated_JJ sheep_NN serum_NN ._.
It_PRP was_VBD found_VBN moreover_RB that_IN washing_VBG the_DT sensitized_VBN RBCs_NNP even_RB six_CD times_NNS made_VBN no_DT difference_NN in_IN the_DT amount_NN of_IN lysis_NN ._.
When_WRB washed_VBN guinea-pig_NN RBCs_NNP 0.05_CD cc_NN are_VBP treated_VBN with_IN fresh_JJ horse_NN serum_NN ,_, concentration_NN 20_CD per_IN tent_NN ._.
in_IN mixture_NN ,_, ``_`` Slight_NNP ''_'' lysis_NN (_( 30_CD per_IN cent_NN ._. )_)
results_NNS ._.
If_IN heated_VBN goat_NN serum_NN is_VBZ present_JJ in_IN the_DT mixture_NN in_IN concentrations_NNS of37_VBP D._NNP 20_CD per_IN cent_NN ._.
suspension_NN rabbit_NN RBCs_NNP sensitized_VBD 1_CD in_IN 20_CD parts_NNS heated_VBD sheep_JJ serum_NN 0.25_CD Partial_JJ 50_CD per_IN cent_NN ._.
Salt_NNP 1.5_CD Fresh_NNP guinea-pig_NN serum_NN 0.25_CD E._NNP Desensitized_NNP serum_NN from_IN D_NNP 1.0_CD Partial_NNP 50_CD per_IN cent_NN ._.
Fresh_JJ guinea-pig_JJ serum_NN 0.25_CD Salt_NNP 0.7_CD Rabbit_NNP RBCs_NNP 0.05_CD If_IN no_DT other_JJ auxilytic_JJ or_CC antilytic_JJ agencies_NNS are_VBP at_IN work_NN a_DT just_RB representation_NN of_IN the_DT amount_NN of_IN lysis_NN occurring_NN should_MD be_VB made_VBN by_IN the_DT following_JJ equation:38_NN had_VBD been_VBN removed_VBN ._.
Complete_JJ lysis_NN on_IN each_DT occasion_NN was_VBD again_RB given_VBN by_IN 15_CD per_IN cent_NN of_IN the_DT serum_NN so_RB no_DT loss_NN of_IN complement_NN was_VBD demonstrable_JJ ._.
The_DT serum_NN was_VBD not_RB tinged_VBN with_IN hæmoglobin_NN as_IN a_DT result_NN of_IN the_DT intravenous_JJ injection_NN ._.
No_DT anaphy-_JJ lactic_JJ symptoms_NNS were_VBD observed_VBN after_IN the_DT second_JJ intravenous_JJ inoculation_NN ._.
Rabbit_NN 101_CD received_VBD 1_CD cc_NNS washed_VBD goat_NN M_NNP RBCs_NNP subcutaneously_RB daily_RB for_IN 6_CD days_NNS ._.
Forty-five_JJ days_NNS later_RB 6.5_CD per_IN cent_NN ._.
of_IN its_PRP$ serum_NN in_IN a_DT total_NN of_IN 2_CD cc_NNS fluid_VBP lysed_VBD 0.05_CD cc_NN goat_NN M_NNP RBCs_NNP completely_RB ._.
It_PRP then_RB received_VBD 6_CD cc_NNS washed_VBD goat_NN M_NNP RBCs_NNP intravenously_RB ._.
Blood_NNP drawn_NN 20_CD and_CC 40_CD minutes_NNS after_IN the_DT injection_NN contained_VBD hæmoglobin_NN ,_, clotted_VBD very_RB slowly_RB and_CC very_RB little_JJ serum_NN separated_VBN from_IN the_DT clot_NN ._.
While_IN 6.5_CD per_IN cent_NN ._.
gave_VBD complete_JJ lysis_NN of_IN goat_NN M_NNP RBCs_NNP before_IN the_DT injection_NN ,_, 50_CD per_IN cent_NN ._.
or_CC 7_CD times_NNS the_DT quantity_NN gave_VBD no_DT lysis_NN either_RB 20_CD or_CC 40_CD minutes_NNS after_IN ._.
This_DT rabbit_NN contained_VBD probably_RB about_IN 130_CD cc_NNS blood_NN or_CC ,_, say_VBP ,_, 65_CD cc_NN serum_NN ._.
If_IN 0.13_CD cc_NN before_IN injection_NN lysed_VBD 0.05_CD RBCs_NNP ,_, 15.6_CD cc_NN would_MD be_VB required_VBN to_TO lyse_VB the_DT 6_CD cc_NN injected_VBN ,_, leaving_VBG about_IN 50_CD cc_NN unaffected_VBN ._.
Theoretically_RB ,_, the_DT lytic_JJ power_NN would_MD have_VB been_VBN reduced_VBN by_IN less_JJR than_IN ¼_NN by_IN the_DT injection_NN ,_, and_CC ,_, instead_RB of_IN lysis_NN of_IN 0.05_CD RBCs_NNP being_VBG accomplished_VBN by_IN 0.I_CD 3_CD cc_NN ,_, 0_CD ._.
I_PRP 7_CD cc_NN would_MD have_VB been_VBN needed_VBN ._.
Actually_RB ,_, however_RB ,_, 1.0_CD cc_NN or_CC nearly_RB six_CD times_NNS that_WDT quantity_NN gave_VBD no_DT appreciable_JJ lysis.The_NN injection_NN ,_, therefore_RB ,_, put_VBD out_IN of_IN action_NN far_RB more_RBR lysin_JJ than_IN was_VBD really_RB needed_VBN for_IN the_DT complete_JJ solution_NN of_IN all_PDT the_DT RBCs_NNP it_PRP contained_VBD ._.
This_DT intra_JJ vitam_NN experiment_NN has_VBZ its_PRP$ counterpart_NN in_IN vitro_NN in_IN the_DT experiment_JJ de-_NN tailed_VBN on_IN p._NN 16_CD in_IN which_WDT ._.
1_CD cc_NN immune_NN serum_NN dissolved_VBD o.6_JJ cc_NN RBCs_NNP in_IN 17_CD minutes_NNS ,_, but_CC ,_, when_WRB the_DT RBCs_NNP were_VBD added_VBN in_IN successive_JJ lots_NNS of_IN 0.2_CD cc_NNS each_DT ,_, lysis_NN was_VBD not_RB complete_JJ in_IN 3_CD hours_NNS ._.
The_DT retardation_NN of_IN the_DT clotting_NN of_IN the_DT rabbit_NN 's_POS blood_NN may_MD have_VB been_VBN due_JJ to_TO the_DT partial_JJ removal_NN of_IN some_DT essential_JJ element_NN such_JJ as_IN calcium_NN from_IN the_DT plasma_NN by_IN the_DT lytic_JJ reaction_NN ,_, or_CC to_TO leucopenia_VB ._.
Chart_NNP No_NNP ._.
10_CD shows_VBZ the_DT lysin_NN content_NN of_IN the_DT rabbit_NN 's_POS serum_NN during_IN the_DT period_NN of_IN its_PRP$ immunisation_NN ,_, and_CC Chart_NNP No_NNP ._.
12_CD that_IN of_IN sheep_JJ R._NNP Sheep_NNP R_NNP received_VBD daily_RB for_IN 6_CD days_NNS 7_CD cc_NN washed_VBD goat_NN M_NNP RBCs_NNP subcutaneously_RB ._.
Forty-five_JJ days_NNS later_RB its_PRP$ serum_NN gave_VBD partial_JJ lysis_NN with_IN goat_NN M._NNP RBCs_NNP (_( 1.95_CD cc_NN serum_NN and_CC 0.05_CD cc_NNS RBCs_NNP )_) ._.
It_PRP then_RB received_VBD 38_CD cc_NNS washed_VBD goat_NN M_NNP RBCs_NNP intravenously_RB ,_, and_CC blood_NN was_VBD drawn_VBN 10_CD ,_, 40_CD and_CC 9.0_CD minutes_NNS later_RB ._.
As_IN in_IN the_DT case_NN of_IN the_DT rabbit_NN there_EX was_VBD haemoglobinaemia_NN ,_, clotting_VBG was_VBD very_RB slow_JJ and_CC very_RB little_JJ serum_NN separated_VBD ._.
There_EX was_VBD probably_RB not_RB enough_RB blood_NN in_IN the_DT sheep_NN to_TO lyse_VB completely_RB all_PDT the_DT goat_NN RBCs_NNP injected_VBD ,_, judging_VBG by_IN the_DT amount_NN of_IN lysis_NN given_VBN by_IN the_DT sample_NN taken_VBN immediately_RB before_IN inoculation_NN ,_, though_RB ,_, had_VBD the_DT injection_NN been_VBN given_VBN 8_CD days_NNS after_IN the_DT last_JJ subcutaneous_JJ inoculation_NN ,_, there_EX would_MD have_VB been_VBN ample_JJ lysin_NN present_NN to_TO have_VB dealt_VBN with_IN the_DT whole_JJ inoculum_NN ._.
The_DT lytic_JJ power_NN of_IN sheep_JJ R_NNP 's_POS serum_JJ deterio-_NN rated_VBN for_IN some_DT unknown_JJ reason_NN very_RB rapidly_RB after_IN reaching_VBG its_PRP$ maximum_NN on_IN the_DT 8th_CD day_NN ,_, and_CC on_IN the_DT 45th_JJ day_NN was_VBD less_JJR than_IN 1/10_CD its_PRP$ previous_JJ maximum_JJ power_NN ._.
The_DT intravenous_JJ injection_NN rapidly_RB removed_VBD all_PDT the_DT available_JJ lysin_NN from_IN sheep_JJ R_NNP serum_NN ,_, so_IN that_IN 10_CD minutes_NNS afterwards_IN no_DT lysis_NN of_IN goat_NN M_NNP RBCs_NNP could_MD be_VB accom-_JJ plished_VBN by_IN it_PRP ,_, even_RB with_IN the_DT aid_NN of_IN added_JJ complement_NN ._.
The_DT sheep_NN passed_VBD hæmo-_JJ globin_NN in_IN its_PRP$ urine_JJ 1½_CD hours_NNS after_IN the_DT injection_NN ,_, but_CC grazed_VBD and_CC showed_VBD no_DT sign_NN of_IN discomfort_NN 4_CD hours_NNS later_RB ._.
During_IN the_DT night_NN ,_, however_RB ,_, it_PRP died_VBD ._.
The_DT autopsy_NN showed_VBD the_DT spleen_NN to_TO be_VB soft_JJ ,_, but_CC not_RB enlarged_VBD ;_: the_DT kidneys_NNS hyperæmic_VBP ;_: the_DT lungs_NNS To_TO face_VB page_NN 38_CD CHART_NNP No_NNP ._.
10_CD Showing_VBG the_DT increase_NN in_IN the_DT lysin_NN content_NN of_IN the_DT serum_NN of_IN rabbit_NN 101_CD as_IN a_DT result_NN of_IN 6_CD subcutaneous_JJ inoculations_NNS of_IN 1cc_CD each_DT of_IN goat_NN RBCs_NNP ._.
C_NNP =_NNP Complete_NNP lysis_NN ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 74918250.tif_CD ]_JJ S.O./1911_NNP Reg_NNP :_: No.1267_NNP Copies_NNPS To_TO face_VB page_NN 38_CD CHART_NNP No_NNP ._.
11_CD Showing_VBG the_DT fall_NN in_IN the_DT percentage_NN of_IN polymorphonuclear_JJ leucocytes_NNS as_IN the_DT immediate_JJ result_NN of_IN the_DT intravenous_JJ injection_NN of_IN goat_NN R_NNP B_NNP Cs_NNP ._.
into_IN sheep_JJ R._NNP [_NNP NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 74918253.tif_CD ]_NNP S._NNP 0./1911_CD Reg_NNP :_: No_DT ._.
1268_CD Copies_NNPS To_TO face_VB page_NN 38_CD CHART_NNP No_NNP ._.
12_CD Showing_VBG the_DT changes_NNS in_IN the_DT amount_NN of_IN lysin_NN in_IN the_DT serum_NN of_IN sheep_JJ R_NNP as_IN a_DT result_NN of_IN 6_CD sub-_JJ cutaneous_JJ inoculations_NNS of_IN 7cc_CD each_DT of_IN goat_NN R_NNP B_NNP Cs_NNP ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 74918256.tif_CD ]_JJ O_NNP =_NNP O_NNP lysis_NN T_NNP =_NNP Trace_NNP P_NNP =_NNP Partial_NNP NC_NNP =_NNP Not_RB complete_JJ C_NNP =_NNP Complete_NNP S._NNP 0./1911_CD Reg_NNP :_: No_DT ._.
1269_CD Copies_NNS 39_CD TABLE_NNP NO_NNP ._.
18_CD ._.
Animal_NNP ._.
Sheep_NNP S._NNP Sheep_NNP R._NNP Rabbit_NNP 101_CD ._.
Relation_NN of_IN RBCs_NNP injected_VBD to_TO weight_NN of_IN animal_NN ._.
1/1920_CD 1/320_CD 1/160_CD Method_NNP of_IN injection_NN 7_CD cc_NN once_RB intravenously_RB ._.
7_CD cc_JJ daily_RB for_IN 6_CD days_NNS sub-_RB cutaneously_RB ._.
1_CD cc_JJ daily_RB for_IN 6_CD days_NNS subcutaneously_RB ._.
Time_NNP which_WDT elapsed_VBD before_IN final_JJ injec-_JJ tion_NN ._.
18_CD days_NNS ._.
45_CD days_NNS ._.
45_CD days_NNS ._.
Relation_NN of_IN RBCs_NNP of_IN test_NN injection_NN to_TO weight_NN of_IN animal_NN ._.
1/790_CD 1/350_CD 1/160_CD Method_NNP of_IN test_NN injection_NN 17_CD cc_NN intravenously_RB ._.
38_CD cc_NN intravenously_RB ._.
6_CD cc_NN intravenously_RB ._.
Result_NN of_IN test_NN Recovery_NN ._.
Death_NNP 20_CD hours_NNS ._.
Death_NNP 1½_CD hours_NNS ._.
The_DT above_NN table_NN shows_VBZ the_DT data_NN of_IN the_DT experiment_NN ._.
The_DT rabbit_NN ,_, whose_WP$ immunity_NN was_VBD the_DT highest_JJS and_CC which_WDT received_VBD the_DT largest_JJS proportionate_NN doses_NNS of_IN washed_JJ sheep_NN RBCs_NNP ,_, was_VBD the_DT first_JJ to_TO succumb_VB to_TO the_DT test_NN injection_NN ;_: Sheep_NNP R_NNP succumbed_VBD after_IN a_DT longer_JJR period_NN and_CC sheep_JJ S_NNP ,_, in_IN which_WDT the_DT presence_NN of_IN immune_JJ body_NN could_MD only_RB be_VB demonstrated_VBN by_IN means_NNS of_IN additional_JJ complement_NN ,_, showed_VBD no_DT ill_JJ effects_NNS ._.
The_DT death_NN of_IN these_DT animals_NNS was_VBD due_JJ to_TO the_DT condition_NN called_VBN anaphylaxis_NN ._.
Anaphylaxis_NNP is_VBZ an_DT accident_NN to_TO an_DT immunised_VBN animal_NN which_WDT can_MD but_CC rarely_RB occur_JJ under_IN natural_JJ conditions_NNS and_CC then_RB only_RB in_IN a_DT modified_JJ degree_NN ;_: and_CC the_DT fact_NN that_IN an_DT animal_NN ,_, when_WRB in_IN an_DT immune_JJ state_NN ,_, is_VBZ under_IN certain_JJ conditions_NNS at_IN the_DT same_JJ time_NN highly_RB susceptible_JJ to_TO an_DT anaphylactic_JJ accident_NN in_IN no_DT way_NN detracts_VBZ from_IN the_DT value_NN to_TO be_VB placed_VBN on_IN acquired_VBN immunity_NN ._.
It_PRP would_MD appear_VB that_IN ,_, in_IN the_DT case_NN of_IN animals_NNS sensitized_VBN to_TO foreign_JJ RBCs_NNP ,_, there_EX is_VBZ a_DT certain_JJ definite_JJ relation_NN between_IN the_DT amount_NN of_IN lysin_NN present_NN in_IN the_DT blood_NN and_CC the_DT amount_NN of_IN the_DT test_NN inoculation_NN which_WDT is_VBZ required_VBN to_TO produce_VB death_NN ._.
Small_JJ quantities_NNS produce_VBP precisely_RB the_DT same_JJ influence_NN as_IN larger_JJR ,_, but_CC of_IN lesser_JJR degree_NN ;_: and_CC the_DT existence_NN of_IN this_DT influence_NN is_VBZ demonstrated_VBN by_IN the_DT leucopenia_NN and_CC proportionate_JJ reduction_NN of_IN the_DT polymorphonuclears_NNS which_WDT occur_VBP ._.
Andrewes_NNP (_( loc_NN ._.
cit_NN ._. )_)
has_VBZ shown_VBN that_IN such_JJ leucopenia_NN is_VBZ due_JJ to_TO the_DT retention_NN of_IN the_DT polymorpho-_JJ nuclears_NNS in_IN the_DT capillaries_NNS of_IN the_DT lungs_NNS whither_IN they_PRP are_VBP conceived_VBN to_TO retire_VB in_IN order_NN to_TO recuperate_VB ,_, whether_IN to_TO renew_VB their_PRP$ stock_NN of_IN complement_NN by_IN oxygenation_NN or_CC for_IN other_JJ purposes_NNS is_VBZ not_RB known_VBN ._.
That_IN the_DT blood_NN is_VBZ not_RB the_DT sole_JJ container_NN of_IN comple-_JJ ment_NN in_IN the_DT body_NN is_VBZ shown_VBN by_IN Todd_NNP and_CC White_NNP (_( Proc_NNP ._.
Roy_NNP ._.
Soc._NNP ,_, Vol_NNP ._.
82_CD ,_, p._RB 418_CD )_) who_WP injected_VBD a_DT powerful_JJ isolytic_JJ serum_NN intravenously_RB into_IN a_DT bull_NN ._.
This_DT serum_NN had_VBD no_DT lytic_JJ action_NN in_IN vitro_NN on_IN the_DT RBCs_NNP of_IN the_DT bull_NN ,_, unless_IN foreign_JJ complement_NN was_VBD added_VBN ,_, and_CC yet_RB the_DT tissues_NNS of_IN the_DT bull_NN somehow_RB furnished_JJ complement_NN in_IN vivo_NN ,_, as_IN bæmoglobinuria_NN followed_VBD ._.
The_DT exact_JJ significance_NN of_IN death_NN by_IN anaphylaxis_NN has_VBZ not_RB yet_RB been_VBN decided_VBN ._.
In_IN the_DT case_NN of_IN the_DT sheep_NN immunised_VBN against_IN goat_NN RBCs_NNP a_DT more_RBR harmless_JJ intravenous_JJ injection_NN than_IN washed_VBD goat_NN RBCs_NNP could_MD scarcely_RB be_VB imagined_VBN ,_, yet_RB death_NN occurred_VBD within_IN 20_CD hours_NNS ._.
Death_NN can_MD scarcely_RB be_VB dependent_JJ on_IN the_DT removal_NN of_IN the_DT immune_JJ body_NN from_IN the_DT serum_NN ,_, for_IN that_DT is_VBZ an_DT artificial_JJ product_NN ,_, and_CC ,_, therefore_RB ,_, in_IN no_DT way_NN essential_JJ to_TO the_DT life_NN of_IN the_DT animal_NN ._.
Nor_CC it_PRP is_VBZ likely_JJ to_TO depend_VB on_IN the_DT removal_NN of_IN complement_NN ,_, whatever_WDT that_DT may_MD be_VB ,_, from_IN the_DT serum_NN ,_, for_IN that_DT substance_NN ,_, if_IN Todd_NNP and_CC White_NNP 's_POS experiment_NN is_VBZ a_DT criterion_NN ,_, can_MD be_VB supplied_VBN from_IN the_DT tissues_NNS ._.
The_DT solution_NN of_IN foreign_JJ RBCs_NNP in_IN the_DT plasma_NN can_MD not_RB enter_VB into_IN the_DT question_NN ,_, for_IN such_JJ solution_NN may_MD occur_VB in_IN the_DT blood_NN of_IN a_DT non-immune_JJ animal_NN without_IN harm_NN to_TO it_PRP ._.
The_DT degree_NN of_IN leucopenia_NN found_VBN is_VBZ not_RB greater_JJR than_IN may_MD be_VB met_VBN with_IN in_IN malaria_NN for_IN example_NN ._.
The_DT dyspn_NN
